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CD36 Mediates Fatty Acid Uptake and Triglyceride
Storage and Contributes to Dyslipidemia Associated
with Diet-induced Obesity
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Consuming diets rich in fatty acids leading to excessive
weight gain has been identified as a major contributor to the
pathogenesis of Type 2 Diabetes (T2D), a known risk factor
for cardiovascular disease. Associated with diet-induced
obesity (DIO) are elevated levels of plasma fatty acids (FA)
and lipoprotein associated triglycerides (TG). Since the levels
of plasma FA and lipoprotein associated TG are primarily
controlled by the liver, it is likely that aberrant hepatic FA
uptake and handling contributes to the dyslipidemia that
precedes development of T2D. Indeed, we have shown that
mRNA and protein expression of the FA transport protein,
CD36,whichisnormallyexpressedatlowlevelsinthe mouse
liver, is significantly elevated during DIO and is correlated
with increased hepatic TG storage and TG secretion as very
low-density lipoproteins (VLDL). In vivo gene delivery of a
recombinant adenovirus harboring CD36 cDNA (Ad.CD36)
into lean mice showed a significant increase in hepatic FA
uptake in vivo and an accumulation in hepatic TG storage
and VLDL-TG secretion compared to Ad.Null-injected mice,
demonstrating that increased CD36 expression alone is
sufficient to recapitulate the alterations in liver lipid storage
and VLDL-TG secretion observed in DIO. Together these
data show that increased hepatic CD36 expression may play
a causative role in the dyslipidemia associated with DIO and
further suggests that inhibition of hepatic CD36 may prove
to be beneficial for the prevention of insulin resistance and
the eventual development of T2D.
OMEGA-3 Polyunsaturated Fatty Acid Incorporation
Improves Oxygen Efficiency and Reduces Skeletal
Muscle Fatigue in Rat
Gregory E. Peoples
1, Peter L. McLennan
2
School of Health Sciences
1 and Graduates School of
Medicine
2, University of Wollongong, Australia.
Background: Fish oil feeding increases incorporation of the
omega-3 polyunsaturated fatty acid (n-3 PUFA) docosahex-
aenoic acid (DHA; 22:6n-3) into both skeletal muscle and
myocardial cell membranes and increases the efficiency of
myocardial oxygen use (1).
Objectives: To test the hypothesis that skeletal muscle
oxygen consumption and fatigue may be influenced by n-3
PUFA.
Methods: Wistar rats were fed one of three diets (NuMega,
High-DHA Tuna Fish Oil; n-3 PUFA, Safflower oil; n-6
PUFA, Saturated fat; SF) for 8w. Oxygen consumption and
muscle function were investigated using the in vivo,a u t o -
perfused, contracting hind limb with isometric tension
development measured from the left gastrocnemius-plantaris-
soleus muscle bundle. Rats, stimulated via the sciatic nerve,
were subjected to 3x 10min (1Hz) stimulation bouts with
30min rest between or a single bout (2Hz) to 50% fatigue.
Results: Skeletal muscle of rats fed the n-3 PUFA, fatigued
more slowly during stimulation compared to n-6 PUFA or
SF, p<0.05 with less decrement in peak tension in
successive stimulation bouts p<0.05. Muscle oxygen
consumption was lowest in the n-3 PUFA group at rest
and during stimulation increased by up to 413% (n-3PUFA)
or 575% (SF) (p<0.05). During fatiguing contractions, hind
limb oxygen consumption relative to developed force was
significantly less in n-3 PUFA rats.
Conclusions: Contracting skeletal muscle from fish oil fed
rats has low oxygen consumption and is fatigue resistant
compared to SF or n-6 PUFA feeding. This may reflect dietary
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(1) Pepe S, McLennan PL. Circulation 2002; 105: 2303–2308.
Myocardial Fatty Acid Oxidation Rates Remain Elevated
in Ob/Ob Mice Despite Reversal of Obesity and Diabetes
by Caloric Restriction
Crystal Sloan, Joseph Tuinei, E. Dale Abel
University of Utah, Salt Lake City, UT, USA
Rationale: Leptin deficient ob/ob mice are commonly used to
study the effects of obesity and insulin resistance on myocardial
substrate metabolism. However, it is difficult to discern the
specific effects of obesity/ insulin resistance/ diabetes versus
leptin deficiency. We therefore adopted a strategy using caloric
restriction to normalize body weight and reverse insulin
resistance to study the effect of leptin deficiency on myocardial
metabolism in lean ob/ob mice.
Methods: Male 4-week old ob/ob mice were “pair fed” to a
leptin-treated group (3mg/kg/day by i.p. injection) for three
weeks. Glucose tolerance, serum insulin, serum triglycer-
ides and FA oxidation rates in hearts perfused with 0.4mM
palmitate±1 nM insulin were determined.
Results: Leptin-treated ob/ob mice ate significantly less than
non-treated ob/ob mice, and their weight returned to wild-
type levels. Hyperglycemia, hyperinsulinemia, hypertrigly-
ceridemia and cardiac hypertrophy were also completely
reversed in leptin-treated ob/ob mice. In contrast, cardiac
hypertrophy persisted in pair fed ob/ob mice and despite
normalization of glucose tolerance and insulin levels, serum
triglyceride concentrations increased by 2 and 6-fold in pair
fed ob/ob mice relative to untreated ob/ob and wild-type
mice, respectively (p<0.05). As previously reported, palmi-
tate oxidation rates were 2.1-fold increased in ob/ob hearts
relative to controls (p<0.005) and were normalized with
leptin treatment. In contrast, palmitate oxidation rates
remained elevated in pair fed ob/ob mice relative to
wildtype controls (1.9-fold, p<0.01). Insulin has a positive
inotropic effect in perfused wildtype hearts, and this effect
is absent in ob/ob hearts. Myocardial insulin sensitivity was
restored by leptin treatment in ob/ob mice, but not in pair
fed ob/ob mice despite equivalent body weights and
glucose tolerance.
Conclusions: These data support a direct antihypertrophic
effect of leptin in the heart and also suggest that leptin
deficiency may directly contribute to myocardial insulin
resistance and abnormal FA metabolism. Potential mechanisms
include increased hepatic triglyceride production in leptin
deficiency or direct effects of leptin signaling in the hypothal-
amus and/or the periphery on myocardial substrate utilization.
Hyperinsulinemic Normoglycemic Clamp Results
in Hypolipidemia During Coronary Artery Surgery
Coert J. Zuurbier, Frans Hoek, Jasper van Dijk and Harry
van Wezel.
Dept. of Anesthesiology and Clinical Chemistry, Academic
Medical Center, Amsterdam
Background This study sought to quantify the effects of a
perioperative hyperinsulinemic normoglycemic clamp on plas-
ma levels of free fatty acids (FFA), triglyceride (TG) lactate and
ketone bodies during coronary artery bypass grafting (CABG).
Methods Forty-four nondiabetic patients with normal left
ventricular function, scheduled for elective CABG, were
randomized to either a control group (n=21) receiving standard
care or to a clamp GIK group (n=23) receiving a perioperative
hyperinsulinemic (0.1 IU kg
−1 h
−1 insulin) normoglycemic
(plasma glucose between 3.0 and 6.0 mmol L
−1)c l a m pd u r i n g
26 h. We measured plasma insulin, glucose, FFA, lactate and
ketone bodies at regular intervals from induction of anesthesia
through the end of the second postoperative day (POD). Test
tube lipolysis was prevented through the use of tetrahydrolip-
statin (orlistat).
Results Inthe control groupFFA peakedat0.76±0.05mM at
early reperfusion and decreased to 0.3–0.5 mM during the
remaining part of the protocol. GIK decreased FFA levels
from 0.38±0.05 mM at early reperfusion, to 0.10±0.01 mM
during the clamp. During the clamp period, GIK reduced the
areaunderthecurveforFFAby75%andforTGby53%.GIK
significantly increased lactate levels during early reperfusion
from 1.2 mM to 1.6 mM. Ketone bodies during the clamp
period were significantly decreased, as reflected by a 50%
smaller area under the curve in plasma ketone bodies.
Conclusions A hyperinsulinemic normoglycemic clamp
during CABG decreases plasma FFA to very low levels of
<0.1 mM, with small increases in lactate and a 50% reduction
in ketone bodies. The very low levels of FFA may diminish
the potential benefits of GIK treatment.
Transgenic Suppression of Amp-Activated Protein Kinase
Activity does not Impair Recovery of Cardiac Power
During Reperfusion of Ischemic Hearts
Clifford D.L. Folmes
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Activation of AMP-activated protein kinase (AMPK) has
been suggested to benefit the heart during ischemia/
134 Cardiovasc Drugs Ther (2008) 22:133–158reperfusion by increasing energy production. While AMPK
stimulates glycolysis, mitochondrial oxidative metabolism
is the major source of cardiac ATP production during
reperfusion of ischemic hearts. Stimulating AMPK
increases mitochondrial fatty acid oxidation, but this is
usually accompanied by a decrease in glucose oxidation. To
examine the relationship between AMPK activation and
cardiac energetics, we measured energy metabolism in
hearts from mice expressing a dominant negative AMPK
α2 (dnAMPK). Isolated working mouse hearts (n=4 hearts/
group) were subjected to 30 min aerobic perfusion, 20 min
global ischemia and 40 min of aerobic reperfusion with
Krebs-Henseleit solution containing 5mM [U-
14C]glucose,
0.4mM [9, 10–
3H]palmitate and 100 μU/ml insulin. As
expected, the dnAMPK hearts had reduced AMPK activity
at the end of reperfusion (82±9 vs 141±7 pmol/mg/min, P
<0.05) with no changes in high-energy phosphates. Despite
this, dnAMPK hearts had improved recovery of contractile
function during reperfusion compared to wildtype controls
(15±0.8 vs 10±1.4 bp mmHg 10
–3, P<0.05). During the
initial aerobic period, rates of glucose oxidation were
higher in the dnAMPK hearts (2060±158 vs 1089±117
nmol/g dry wt/min, P<0.05) but palmitate oxidation was
not different. Therefore total TCA cycle activity was also
elevated (5.2±0.3 vs 3.2±0.5 μmol/g dry wt/min, P<0.05),
which is not accounted for with a 12% increase in function.
These data demonstrates that suppression of cardiac AMPK
activity does not produce an energetically compromised
phenotype and does not impair, but may in fact improve,
the recovery of mechanical function following ischemia.
The AMPK-induced P70s6k Inhibition Participates in
the Synergistic Effect of Biguanides and Insulin on
Glucose Uptake Via the Overphosphorylation of the
Pkb/As160 Axis
Christophe Beauloye
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Background: Biguanides, like metformin and phenformin,
are known to lower blood glucose concentration by
increasing muscle glucose disposal. Several findings sug-
gest that the effects of biguanides could be mediated by the
activation of AMP-activated protein kinase (AMPK). The
aim of this work was to study the relationship between
AMPK and the biguanide-stimulated glucose uptake in
cardiomyocytes.
Methods: Cultured rat cardiomyocytes were incubated with
insulin and phenformin, alone or in combination. Glucose
uptake was measured by the detritriation rate of [2–
3H]
glucose. The phosphorylation state of the different signal-
ling elements was measured by immunoblot.
Results: The stimulation of glucose uptake by biguanides
correlated to AMPK phosphorylation, whereas that by insulin
correlated with protein kinase B (PKB) phosphorylation.
When added together, insulin and phenformin induced a
concomitant increase in AMPK phosphorylation and PKB
overactivation, resulting to a synergistic overstimulation of
glucoseuptake.Thisphenformin-inducedPKBoveractivation
is accompanied by the inhibition of p70 ribosomal S6 kinase
(p70S6K) and of the phosphorylation of insulin receptor
substrate 1 (IRS-1) onserine, bothpresumed tobeinvolved in
thenegativefeedbackinhibitionoftheinsulinsignalling.Inall
conditions, PKB and AMPK activation fully correlated to the
phosphorylation of Akt-substrate 160 (AS160), known to
participate in glucose uptake stimulation.
Conclusions: AMPK activators induced overstimulation of
glucose uptake in insulin-treated cardiomyocytes via the
inhibition of the p70S6K negative feedback loop. This is
accompanied by the overphosphorylation of thePKB/AS160
axis. Our results suggest that AMPK activation could be a
potential therapeutic approach to treat insulin resistance.
Hyperthyroidism Increases Substrate Metabolism in
Proportion to Increased Contractile Function and
Hypertrophy in the Rat Heart
Lisa C Heather
a, Mark A Cole
a, Richard P Leoni
a, Rhys
Evans
b and Kieran Clarke
a
aCardiac Metabolism Research Group, Department of
Physiology, Anatomy and Genetics, University of Oxford,
Oxford, UK.
bNuffield Department of Anaesthetics, Uni-
versity of Oxford, Radcliffe Infirmary, Oxford, UK.
Objectives: Thyroid hormones have positive chronotropic
and inotropic effects on the heart. We set out toinvestigate the
effects of triidothyronine on cardiac substrate metabolism in
the isolated, perfused, contracting heart.
Methods and Results: Triiodothyronine (0.2 mg kg body
weight
-1 day
-1 ip for 7 days) injected daily to male Wistar
rats, increased heart weight by 34% and elevated plasma free
fatty acids (FFA) by 97%, compared with controls. Basal
glycolytic rates per gram wet weight (gww) were the same
for all hearts, but insulin-stimulated glycolysis was increased
by 33% in hyperthyroid hearts. Palmitate oxidation and
myocardial lipid incorporation rates were the same per gww
for all hearts, with fatty acid metabolism increasing in
proportion with the increased heart weight in the hyperthy-
roid hearts. There was a positive correlation between cardiac
function and both fatty acid oxidation and glycolytic rates.
Normalisation of metabolic rates to contractile function
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hearts. Protein levels of the fatty acid transporter, fatty acid
translocase (FAT/CD36), were reduced by 46% in the
hyperthyroid heart, and correlated negatively with plasma
FFA concentrations. The protein levels of the other fatty
acid transporters, plasma membrane and cytosolic fatty acid
binding protein (FABPpm and cFABP) and fatty acid
transport proteins (FATP) 1 and 6, were unchanged.
Conclusions: The hyperthyroid rat heart has increased
substrate metabolism in proportion to increased contrac-
tile function and hypertrophy, resembling a physiological
model of hypertrophy. The decreased FAT/CD36 protein
levels may be to limit excessive fatty acid uptake in
conditions in which circulating fatty acids levels are
elevated.
Enhancing cGMP Signaling in the Dystrophin-Deficient
Heart Improves Contractile Function, Sarcolemmal
Integrity and Mitochondrial Metabolism
Maya Khairallah
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Rationale. We recently found early metabolic alterations in
the dystrophin-deficient mdx heart that precede overt cardio-
myopathy and may represent an early “sub-clinical” signa-
ture of a defective NO/cGMP pathway. Therefore, we
hypothesize that early activation of this pathway, down-
stream of NO formation, will confer protection to mdx hearts
by enhancing their resistance to stress and reversing
potentially maladaptive metabolic alterations.
Methods. We generated mdx mice overexpressing in a
cardiomyocyte-specific manner guanylate cyclase (mdx/Tg)
and assessed the metabolic and functional profile of these
hearts using ex vivo perfusions in the working mode and a
13C-methodology.
Results. Compared to mdx mice, mdx/Tg hearts from 12
weeks-old mice showed improved membrane integrity as
evidenced by a 82±13% lower lactate dehydrogenase
release while maintaining similar contractile function. In
the presence of the transgene, the previously observed shift
towards a preferential use of carbohydrates for energy
production in the 12 weeks-old mdx heart was emphasized,
suggesting that this shift is adaptive. Nevertheless, myo-
cardial citric acid cycle pool size was increased by 36±8%
(p<0.05), indicating improvement of previously docu-
mented mitochondrial metabolic alterations. With disease
progression, at 5 months of age, membrane integrity was
significantly improved by 63±12% and associated with a
179±30% increase in cardiac power (p<0.05).
Conclusion. Enhancing cGMP signaling in the dystrophin-
deficientheartimprovedsarcolemmalintegrityandcontractile
performance. These benefits were associated with reversal of
potentially maladaptive mitochondrial metabolic alterations,
and constitute a potential clinical therapeutic avenue for the
dystrophic cardiomyopathy. (Funded by CIHR and HSFC)
The AMPK Gamma 1 R70q Mutant Regulates Multiple
Metabolic and Growth Pathways in the Cardiac Myocyte
Karalyn D Folmes
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2, Michael F Allard
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4Children’s
Nutrition Research Center, Baylor College of Medicine,
Houston, TX
AlthoughmutationsintheγsubunitofAMP-activatedprotein
kinase (AMPK) result in excessive glycogen accumulation
and cardiac hypertrophy, the mechanisms by which this
occurs have not been well defined. As greater than 65% of
cardiac AMPK activity is associated with the γ1s u b u n i to f
AMPK, we investigated the effects of expression of an
AMPK-activating γ1 subunit mutant (γ1 R70Q) on regulato-
ry pathways controlling glycogen accumulation and cardiac
hypertrophy in neonatal rat cardiac myocytes. While expres-
sion of γ1 R70Q displayed the expected increase in palmitate
oxidation rates, rates of glycolysis were significantly de-
pressed. Additionally, glycogen synthase activity was in-
creased in cardiac myocytes expressing γ1 R70Q, as a result
of both increased expression and decreased phosphorylation
of glycogen synthase. The inhibition of glycolysis and
increased glycogen synthase activity were correlated with
elevatedglycogenlevelsinγ1R70Q-expressingmyocytes.In
association with the reduced phosphorylation of glycogen
synthase, glycogen synthase kinase (GSK)-3β protein and
mRNA levels were profoundly decreased in the γ1R 7 0 Q -
expressing myocytes. As GSK-3β is also a negative regulator
of hypertrophy via inhibition of nuclear factor of activated T
cells (NFAT), the dramatic down-regulation of GSK-3β
increased the nuclear activity of NFAT. Together, these data
provide important new information as to the mechanisms by
which a mutation in the γ subunit of AMPK causes altered
AMPK signaling and have identified multiple pathways
involved in regulating both cardiac myocyte metabolism and
growth that may contribute to the development of the γ
mutant-associated cardiomyopathy in humans.
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Fatty Acids Increases Plasma Adiponectin and Prevents
Ventricular Remodeling and Dysfunction with Pressure
Overload
W.C. Stanley, M.K. Duda, K.M. O’Shea, B. Lei, B.R.
Barrows, A.M. Azimzadeh, T.E. McElfresh, B.D Hoit
University of Maryland, Baltimore, and Case Western
Reserve University, Cleveland, USA
Epidemiological studies suggest consumption of ω-
3-polyunsaturated fatty acids (ω-3-PUFA) decreases the risk
for heart failure. In addition, recent studies show dietary
supplementation with ω-3-PUFA from fish increases the
secretion of adiponectin, a cardioprotective adipokine. We
hypothesized that supplementation with ω-3-PUFA from fish
oil increases plasma adiponectin and improves the adaptation
of the left ventricle (LV) to arterial pressure overload. Rats
underwent abdominal aortic banding or sham surgery (n=9–
12/group), and were fed standard chow or ω-3-PUFA
supplemented chow (2.8% of energy intake as eicosapentae-
noic acid + docosahexaenoic acid) for 8 weeks. Banding
increased LV mass to a greater extent with the standard chow
(31%) than with ω-3-PUFA (18%) (p<0.05). With standard
chow banding increased LVend diastolic and systolic volumes
by 19% and 105%, respectively, however they were
unchanged with ω-3-PUFA. Adiponectinm R N Ae x p r e s s i o n
in adipose tissue was increased >2-fold with ω-3-PUFA, and
plasma adiponectin concentration was elevated by ∼30% (p<
0.05), which correlated inversely with LVend systolic volume
(r=−0.46; p<0.05) in the banded animals. Supplementation
with ω-3-PUFA did not affect expression of PPARα regulated
genes in the heart. Total protein expression of the pro-growth
serine-threonine kinase Akt was increased ∼two-fold by ω-3-
PUFA, but the fraction of Akt in the active phosphorylated
form was decreased, and thus there were no differences in the
amount of active P-Akt. The levels of total and phospho-
AMPK were unaffected by either banding or diet.
In conclusion, dietary supplementation with ω-3-PUFA
prevented pressure overload induced LV dysfunction,
which was associated with elevated plasma adiponectin.
Resveratrol Activates Amp-activated Protein Kinase and
Inhibits NFAT-Responsive Promoter Activity to Blunt
Phenylephrine-Induced Cardiac Myocyte Hypertrophy
Anita Y. M. Chan, Carrie-Lynn M. Soltys, and Jason R. B.
Dyck
Cardiovascular Research Group, Departments of Pediatrics
andPharmacology, Faculty of Medicine, University of Alberta,
Edmonton, Alberta, Canada T6G 2S2
Resveratrol, a polyphenol, has been attributed to some of
the cardioprotective effects of red wine consumption,
including the ability to inhibit hypertrophy via its antiox-
idant properties. Recently, resveratrol was found to activate
AMP-activated protein kinase (AMPK) via indirect phos-
phorylation in hepatocytes. However, it is currently
unknown whether resveratrol can also activate cardiac
AMPK and the functional consequence of this. As we have
shown that activation of AMPK inhibits protein synthesis
associated with cardiac hypertrophy, we hypothesized that
an additional mechanism by which resveratrol inhibits
hypertrophy is via AMPK activation. To investigate this,
neonatal rat cardiac myocytes were treated with vehicle or
50 μM resveratrol for 24 hours and 10 μM phenylephrine
to induce hypertrophy. Activation of AMPK was achieved
with resveratrol even in the presence of phenylephrine.
[
3H]-phenylalanine incorporation revealed that resveratrol
significantly decreased protein synthesis induced by phen-
ylephrine. This was associated with reduced activities of
regulators of protein synthesis, namely p70S6 kinase and
eukaryotic elongation factor-2 (eEF2), as shown by phos-
phorylation changes on immunoblots. Specifically, resvera-
trol countered the effects of phenylephrine by blunting the
increase in p70S6 kinase phosphorylation while partially
restoring eEF2 phosphorylation. Furthermore, resveratrol
dramatically decreased nuclear factor of activated T-cells
(NFAT) promoter activity, as demonstrated by reduced
luciferase activity driven by a NFAT-responsive luciferase
reporter transgene. As the calcineurin-NFAT pathway is
thought to be involved in pathological hypertrophy, this not
only provides further evidence that AMPK activation has
therapeutic potential, but also reveals another mechanism by
which resveratrol can prevent hypertrophic growth.
Substrate Oxidation Patterns and Insulin Sensitivity of
the Isolated Working Rat Heart after Exercise Training
or Chronic Pressure Overload
Gracjan Pytel, Vitaly Maks, Michael Schwarzer, Torsten
Doenst
University of Leipzig and Heart Center Leipzig, Germany
Hypothesis: We compared substrate oxidation patterns and
the effect of insulin in isolated working rat hearts with
physiological or pathological hypertrophy.
Methods: Physiological hypertrophy was induced by
treadmill running of male Sprague Dawley rats for 10
weeks (TR). Pathological hypertrophy was induced by
aortic banding for 10 weeks (AoB). Contractile function
and hypertrophy grade was assessed by echocardiography.
Glucose and fatty acid oxidation with or without insulin
Cardiovasc Drugs Ther (2008) 22:133–158 137 137stimulation were assessed in the isolated working heart with
radioactive tracers.
Results: Both interventions caused significant hypertrophy
(LVPWD +28% TR, +68% AoB, both p<0.01). Ejection
fraction was lowest after AoB (70±0.11%) and highest after
TR (82±0.06%) but the differences were not significant
among groups. Isolated heart had lowest cardiac power
after AoB (mW/gdry: 11.8±4.85 vs. 40.8±1.65 in Control,
p<0.01). TR did not affect cardiac power. Decreased
cardiac power after AoB was associated with the lowest
fatty acid oxidation rates (μmolOleat/min/gdry AoB:0.29±
0.06, TR:0.92±0.31, Control:0.94±0.25 p<0.01). Glucose
oxidation was decreased in both hypertrophy groups
(μmol/min/gdry: AoB:0.30±0.06, TR:0.23±0.15, Control:
0.53±0.12, p=0.014). Insulin stimulation increased glucose
oxidation (μmol min
−1 g
−1dry: AoB to 0.64±0.25, TR: to
0.97±0.38, Control: to 1.64±0.46). The relative increase was
greatest in TR (+480%) and smallest in AoB (+105%).
Insulin caused a reduction in fatty acid oxidation, which was
similar in all groups (AoB:-50%, TR:-52%, Control:-50%).
Conclusions: Physiological hypertrophy is associated with
an unexpected decrease in basal glucose oxidation but an
increased responsiveness towards insulin. Pathological hyper-
trophy demonstrates decreased substrate oxidation rates in the
isolated heart associated with reduced function and insulin
sensitivity.
Metabolic Alterations Beyond Fatty Acid Oxidation in
PPARα Null Mice Hearts
R Gélinas
1, B Bouchard
1, J McDuff
1, G Charron
1 and C.
Des Rosiers
1.
1Departments of Nutrition, Montreal Heart Institute, Uni-
versity of Montreal, Quebec, Canada.
Background and Objective: While a shift from fatty acid
(FA) to carbohydrates (CHO) is considered beneficial for the
heart, it is unclear why subjects with FA β-oxidation (FAO)
defects are prone to cardiac decompensation under stress
conditions. In this study, we sought for alterations in
myocardial CHO metabolism and its regulation using PPARα
null mice as our animal model of FAO defects.
Methods:
13C-methodology was used to assess substrate
flux through energy yielding pathways in hearts perfused ex
vivo at two workloads. The expression of selected
metabolic genes was also assessed using real time PCR.
Results: Compared to control C57BL/6 mice, working
hearts from PPARα null mice displayed an impaired
capacity to withstand a raise in preload, as reflected by a
20% decline in aortic flow and cardiac efficiency. Beyond
the expected shift from FA (four-fold down) to carbohy-
drate (CHO: 2-fold up) (p<0.001) at both preloads, these
hearts depicted a 44% lower glycolytic flux rate when
expressed relative to that of pyruvate decarboxylation at the
higher preload (p<0.05), suggesting a mismatch between
cytosolic and mitochondrial CHO metabolism. One poten-
tial mechanism for this mismatch is suggested by a 68%
decrease in the gene expression of ATP-citrate lyase, an
enzyme that may determine cytosolic levels of citrate, an
inhibitor of glycolytic phosphofructokinase, in PPARα null
mice hearts (p<0.05).
Conclusion: Collectively, our data highlight metabolic
alterations in PPARα null mice hearts, beyond their lower
FAO, which may be determinant for their response to an
increase in workload. (Supported by CIHR and NIH).
High-Fat Feeding Increases Fatty Acid Oxidation Rates
and Uncouples Respiration in Cardiac Mitochondria
Andrew J Murray, Sara McAleese, Lindsay M Edwards
and Kieran Clarke
University of Oxford, Department of Physiology, Anatomy
and Genetics, Parks Road, Oxford, UK, OX1 3PT
High-fat feeding in rats decreases cardiac efficiency (hy-
draulic work/O2 consumption) and impairs exercise capac-
ity. The aim of this study was to determine whether high-fat
feeding alters mitochondrial respiration in the heart by
increasing uncoupling protein 3 (UCP3) levels. Male Wistar
rats were fed standard chow (n=6) or high-fat diet (55%
saturated fat) (n=6) for one month. Hearts were excised and
interfibrillar and subsarcolemmal mitochondria isolated.
State III and state IV respiration rates were measured using
an oxygen electrode, with glutamate or palmitoyl-carnitine
as substrates, and ADP/O ratios were calculated. Interfi-
brillar mitochondria from high-fat fed rats had higher state
III respiration rates with palmitoyl-carnitine than those from
chow-fed animals, and had lower ADP/O ratios, indicating
uncoupling of oxidation/phosphorylation with both sub-
strates. ADP/O ratios were the same in both groups in the
presence of GDP, a UCP3 inhibitor (see Figure). Sub-
sarcolemmal mitochondria from high-fat fed rats had higher
state III respiration rates with palmitoyl-carnitine than those
from chow-fed rats, and again had lower ADP/O ratios with
both substrates. As with interfibrillar mitochondria, ADP/O
ratios were the same in both groups in the presence of GDP.
Cardiac UCP3 and mitochondrial thioesterase-1 protein
levels, measured using immunoblotting, were both 20%
higher in high-fat compared with chow-fed rats, with no
difference in levels of the mitochondrial respiratory chain
complexes. In conclusion, high-fat feeding increased
mitochondrial fatty acid oxidation and uncoupled respira-
tion via elevated UCP3 levels, probably through PPARα
activation.
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Figure a) State III and state IVrespiration rates, and b) ADP/O ratios
in interfibrillar mitochondria isolated from chow and high-fat fed rat
hearts with palmitoyl-carnitine as substrate, and in the presence and
absence of GDP, a UCP3 inhibitor.
*P<0.05 compared with same parameter in interfibrillar mito-
chondria from chow-fed rat hearts.
UCP 3 Does Not Regulate Fatty Acid Oxidation Rates
in the Heart but Controls Cardiac and Skeletal Muscle
ROS Production
Sihem Boudina, Joseph Tuinei, Heather Theobald, Sandra
Sena and E. Dale Abel
Division of Endocrinology, Metabolism and Diabetes and
Program in Human Molecular Biology and Genetics,
University of Utah School of Medicine, Salt Lake City,
Utah 84112.
The biological functions of uncoupling protein 3 (UCP3) in
cardiac muscle are incompletely understood and its role
in maintaining coupling of oxidative phosphorylation in
skeletal muscle is controversial. These studies were
designed to investigate the role of UCP3 in cardiac and
skeletal muscle energy metabolism under normal and high
fat diets. Mice lacking UCP 3 (UCP3KO) and wildtype
(WT) littermates were fed a normal chow (NC) or a high fat
(HF) diet for 10 weeks. Palmitate oxidation (POX),
myocardial oxygen consumption (MVO2), cardiac efficien-
cy (CE) and cardiac power were determined in isolated
working hearts. Mitochondrial respiration and ATP synthe-
sis were determined in saponin-permeabilized soleus and
cardiac muscle. Oxidative damage was determined using
dichlofluorescein (DCF). On NC, POX rates were similar
between UCP3KO and WT but increased similarly with HF
(726.5±41.8 vs. 731.7±47.1 nmol/min/mg DHW). MVO2,
which increased in WT with HF (P<0.05) did not increase
in UCP3KO on a HF. CE and cardiac power were reduced
in WT with HF but preserved in UCP3KO on HF. State 2, 3
and 4 were not different in cardiac and soleus fibers from
WT and UCP3KO on NC. Compared to NC, state 4
respiration increased with HF by 26% and 34% in cardiac
mitochondria from WT and UCP3KO respectively. On HF,
ATP synthesis increased by 19% and 28% (P<0.05) in
soleus and cardiac mitochondria from UCP3KO. Reactive
oxygen species (ROS) generation was 49% (P<0.005)
higher in hearts from WT on HF compared to WT on NC.
However, ROS generation was further increased in
UCP3KO on HF (212.1±16.2 versus 177.8±9.1, P<0.05).
In skeletal muscle, ROS generation was not increased in
WTon the HF diet but rose by 18% (P<0.005) in UCP3KO
on HF compared to UCP3KO on NC. In conclusion, UCP3
mediates the increase in MVO2 that accompanies HF
feeding and contributes to reducing fat-induced ROS
accumulation. Despite these effects, mitochondrial ATP
generation increased, indicating that UCP3 also regulates
the efficiency of mitochondrial ATP generation.
Dietary Fish-Oil Preserves Cardiac Contractile Function
by Upregulation of Ucp3 in a Rat Model of High-Fat
Diet-induced Glucose Intolerance and Cardiomyopathy
D.M. Ouwens
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2,J .K r i e k
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Background and Aims: Myocardial insulin resistance and
lipotoxicity, leading to mitochondrial dysfunction and oxida-
tivestress,havebeenimplicatedinthe developmentofdiabetic
cardiomyopathy (DCM), a common complication in type 2
diabetes mellitus. Uncoupling protein 3 (UCP3) has been
proposed to protect against lipid-induced mitochondrial
damage, either by exporting excessive fatty acid anions from
the mitochondrial matrix and/or by reducing mitochondrial
ROS production and lipid peroxide formation, thus being an
important protective mechanism in diabetes-related organ
damage. We studied whether diet-induced alterations in
myocardial insulin sensitivity and in vivo cardiac function in
rats could be ascribed to changes in UCP3 protein expression.
Materials and Methods: Male Wistar rats, fed isocaloric
low-fat- (LF), high-fat- (HF), or high-fat fish-oil-enriched
(FISH) diets, underwent an oral glucose tolerance test
(oGTT) at day 25, and in vivo echocardiography at day 27.
Rats were sacrificed at day 28 for analysis of myocardial
protein expression and phosphorylation.
Results: No significant differences in body weight gain,
fasting plasma glucose and insulin levels were found
among the diet-groups. However, compared to LF-diet fed
rats, HF- and FISH-diet fed rats showed glucose intolerance
in the oGTT (P<0.05). Also insulin-mediated activation of
the PKB/Akt-pathway was 40–50% lower in hearts from
both HF- and FISH-diet fed rats, compared to LF-diet fed
Cardiovasc Drugs Ther (2008) 22:133–158 139 139hearts (P<0.05). Interestingly, cardiac contractile function,
expressed as fractional shortening and ejection fraction, was
similar in FISH- and LF-diet fed rats, but was decreased in
HF-diet fed rats (P<0.05 versus FISH). Myocardial protein
levels of UCP3 were 1.9-fold increased in FISH-diet fed
rats compared to LF-diet fed rats (P<0.01), but failed to
rise significantly in HF-diet fed rats.
Conclusion: FISH-oil enriched diet induced myocardial
UCP3 expression while preserving cardiac contractile
function in rats. We propose that dietary FISH-oil prevents
lipotoxic heart disease by upregulation of UCP3, rather
than by improving myocardial insulin signalling, in a rat
model of diet-induced glucose intolerance.
High Fat Fed Heart Failure Animals have Enhanced
Mitochondrial Function and Acyl-CoA Dehydrogenase
Activities
Julie H Rennison
1, Martin E Young
2, Charles L Hoppel
1,
Margaret P Chandler
1
Case Western Reserve University, Cleveland, OH; Baylor
College of Medicine, Houston, TX
2, USA
We have previously shown that administration of high fat in
heart failure (HF) increased mitochondrial respiration and
did not alter left ventricular (LV) function. PPARα is a
nuclear transcription factor that activates expression of genes
involved in fatty acid uptake and utilization. We hypothe-
sized that elevated mitochondrial respiration in high fat fed
HF rats is due to increased expression of β-oxidation
enzymes (short (SCAD), medium (MCAD), and long
(LCAD) chain acyl-CoA dehydrogenase). Rats underwent
ligation or sham surgery and were fed normal (10% kcal fat)
(SHAM, HF) or high fat diet (60% kcal saturated fat)
(SHAM+FAT, HF+FAT) for 8 weeks. Subsarcolemmal and
interfibrillar mitochondria were isolated from the LV. State 3
respiration using fatty acid substrates octanoylcarnitine and
palmitoylcarnitine was increased in HF+FAT compared to
SHAM+FAT and HF respectively (242±21, 246±21 vs 183
±8, 181±6 and 193±17, 185±16 nAO/min/mg). Despite
decreasedmcad mRNA in HF and HF+FAT, MCAD protein
was not different between groups, and MCAD activity in-
creased in HF+FAT (65.1±2.7 vs 81.5±5.4 nmol/min/mg).
ActivitiesofSCADandLCADwerealsoelevatedinHF+FAT
though scad and lcad mRNA expression were not different.
SCAD, MCAD, and LCAD activities correlated to increased
state 3 respiration using both fatty acid substrates. In
conclusion, enhanced mitochondrial respiration associated
with high fat may result from increased activation of acyl-
CoA dehydrogenases, but is not due to increased mRNA or
protein expression. High fat in normal animals did not
adversely affect mitochondrial respiration or the expression
and activity of enzymes involved in β-oxidation.
Regulation of Cardiac Substrate Utilization by Protein
O-Glycosylation
Arzu Onay-Besikci
1, Norbert Fülöp
2, Richard B Marchase
2,
John C Chatham
2
1Faculty of Pharmacy, Ankara University, Turkey;
2Univ.
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Increased hexosamine biosynthesis (HB) flux and O-linked
attachment of N-acetyl-glucosamine (O-GlcNAc) on nucle-
ocytoplasmic proteins have both been implicated in diabetic
cardiomyopathy. The goal of this study was to determine
the impact of acute increases in HB flux and O-GlcNAc
levels induced by glucosamine (GlcN) on cardiac function
and substrate metabolism. Metabolic fluxes were deter-
mined in isolated hearts perfused with
13C-labeled sub-
strates and 0, 0.05, 0.1, 1, 5 and 10 mM GlcN using
13C-NMR isotopomer analysis. UDP-GlcNAc, a product of
HB and a precursor of O-GlcNAc was assessed by HPLC
and protein O-GlcNAc levels were assessed by immunoblot
analysis. GlcN had no effect on cardiac function at any
concentration; however, both UDP-GlcNAc and O-GlcNAc
were significantly increased with GlcN treatment with a
maximal response at 1 mM GlcN (∼2-fold increase vs
0mM; p<0.05). The addition of 0.05 mM GlcN signifi-
cantly increased the contribution of palmitate (47±3% vs
56±1%, p<0.05), and decreased the contribution of lactate
(28±3% vs 19±1%, p<0.05) to oxidative metabolism.
Increasing GlcN to 0.1 mM further increased palmitate
oxidation and reduced lactate oxidation; however, higher
concentrations had no additional effect on substrate
utilization. Thus, GlcN significantly increased O-GlcNAc
levels and altered fatty acid and carbohydrate oxidation in a
similar manner to that seen with diabetes. These data
suggest that changes in O-GlcNAc levels may contribute to
the shifts in cardiac substrate utilization seen in diabetes.
S u p p o r t e di np a r tb yT U B İTAK 2219 (AOB); NIH
HL067464, HL079364 (JCC); NIH HL076175 (RBM).
CARDIAC Lipid Accumulation and Cardiac Function
in Well-Controlled Type 2 Diabetes Mellitus Patients
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140 Cardiovasc Drugs Ther (2008) 22:133–158Background: In cardiomyocytes, lipids and lipid metabolites
can act as cardiotoxins, impairing cardiac function and
increasing the risk for dilated cardiomyopathy. As the preva-
lence of cardiomyopathy is high in type 2 diabetes mellitus
(T2DM), an increased deposition of intra-cardiocellular lipids
(ICCL) may be expected.
Objective: To develop, validate and apply a non-invasive
method to quantify ICCL in subjects with T2DM and BMI-
matched controls and to relate outcomes to recognized
clinical markers of cardiac function.
Methods: So far, 6 patients with well-controlled T2DM
and 12 controls were metabolically phenotyped and
included in the study (age(y): 60.2±0.5 vs 61.8±2.7,
BMI(kg/m
2): 29.9±1.0 vs 29.0±0.7, T2DM vs controls, all
males). Magnetic resonance imaging was used to investi-
gate the hemodynamic cardiac function, and proton
magnetic resonance spectroscopy to quantify ICCL in the
intraventricular septum of the heart. Cardiac triggering and
breathing commands were used to compensate for cardiac
and respiratory motion. Measurements were performed on a
1.5T whole-body system (Intera, Philips Medical Systems).
Results: The correlation of repeated ICCL-measurements
was good (R=0.96; p<0.05)). The results show that ICCL
is higher in T2DM, but the difference did not reach
statistical significance (15.4±4.1 vs 10.8±1.5 mmol/g, p=
0.216). Interestingly, the variation between subjects is large
in T2DM, suggesting that subtypes of diabetes may be
more affected. ICCL content tended to correlate with the
concentricity index (leftventricular mass/leftventricular vol-
ume, n=14, R=0.528, p=0.05).
Conclusions: Here we present a reproducible, non-invasive
method to quantify ICCL in humans. Inclusion of addition-
al subjects is needed to make a definitive statement on
ICCL content in T2DM. The preliminary data further
indicate that an increased cardiac lipid content is accompa-
nied by a concentric remodeling of the heart.
This work was made possible by a grant from the EFSD/
Lilly Research Fund. VB S-H was supported by a Kootstra
Fellowship.
Low Threshold Intake of Fish Oil for Myocardial
Omega-3 Fatty Acid Incorporation is Not Subject
to Competition with Omega-6 Fatty Acids
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1Graduate School of Medicine,
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Background – Regular intake of fish or fish oil is
associated with reduced risk of cardiovascular disease.
Animal studies provide biologically plausible bases for
omega-3 polyunsaturated fatty acids (PUFA) associated
with incorporation into myocardial membrane phospholip-
id; however a link between regular low intakes of fish oil
and membrane change has not been demonstrated, espe-
cially in the context of high omega-6 PUFA background
diet.
Objective - To establish the dose-response of very low
dietary FO intake in the rat and the influence of dietary
omega-6 PUFA on heart omega-3 PUFA incorporation.
Methods - Rats were fed diets containing 0.12%en – 8.7%
en as EPA+DHA from FO compared to 0% FO, with
background diets containing either 1.5%en or 7.5%en as
omega-6 PUFA (linoleic acid) for 4w.
Results - Fish oil increased heart omega-3 content (mainly
DHA) by 1.7 to 3.3 fold (from 7% (at 0%FO) to 25%
membrane fatty acids) in a log-linear fashion with little
EPA incorporation. A dietary threshold for membrane
incorporation was established at 0.02%en EPA+DHA. High
dietary n-6 PUFA had no significant effect on the slope or
threshold for heart DHA incorporation.
Conclusions- Heart cell membranes are sensitive to the
absolute amounts of long-chain omega-3 PUFA in the diet
but not to the dietary ratio of omega-6/omega-3 PUFA,
even at very low fish oil intakes. Doubling of rat
myocardial membrane omega-3 PUFA composition was
achieved with %energy intakes equivalent to human intake
of 1–2 meals of fatty fish per week.
Nutritional Preconditioning of the Rat Heart by Dietary
Fish Oil
Peter L. McLennan
1, Grace G. Abdukeyum
2
1Graduate School of Medicine,
2School of Health Sciences,
University of Wollongong, NSW 2522, Australia
Background: Dietary fish oil provides a range of cardiopro-
tective effects associated with myocardial incorporation of
long-chain omega-3 polyunsaturated fatty acids (n-3 PUFA).
They prevent arrhythmias, lower heart rate and reduce
oxygen consumption without detriment to work output.
Objectives: To compare the effects of dietary fish oil
with those of ischaemic preconditioning during ischemia/
reperfusion.
Methods: Rats were fed diets with fish oil (n-3 PUFA),
sunflower seed oil (n-6 PUFA) or saturated fat (beef tallow)
(SF) for 6 weeks. Isovolumic, isolated perfused hearts were
reperfused for 120min after 30min regional ischemia, with
Cardiovasc Drugs Ther (2008) 22:133–158 141 141or without ischaemic preconditioning (3x 5min cycles of
global ischemia).
Results: Ischemic preconditioning significantly reduced
heart rate, coronary flow and end-diastolic pressure (EDP)
at rest, reduced EDP rise in ischaemia/reperfusion, in-
creased developed pressure recovery and reduced arrhyth-
mias post-ischaemia, but only in SF and n-6 PUFA hearts.
The n-3 PUFA hearts had lower coronary flow, heart rate
and EDP at rest. Post-ischaemic arrhythmias, heart rate,
coronary flow and EDP rise were reduced, and recovery of
developed pressure and maximum rate of relaxation were
increased.
Conclusions: Prefeeding with n-3 PUFA provided cardio-
protection, improving recovery, reducing stunning and
arrhythmia while ischemic preconditioning provided similar
but no additional protection in n-3 PUFA hearts. We
conclude that dietary fish oil produces a preconditioning-
like effect with chronic administration, which by virtue of
the continuous presence of n-3 PUFA in the membrane is
apparently not subject to desensitisation.
Omega-3 Fatty Acids in Human Heart: Correlation
Between Atria, Ventricle and Erythrocytes
Mandy L Theiss
1, Peter L McLennan
1, Salvatore Pepe
2,
Freya Sheeran
2
1University of Wollongong,
2Monash University, Australia
Background: Omega-3 polyunsaturated fatty acids (PUFA)
are cardioprotective in animals. Human red blood cell
(RBC) eicosapentaenoic acid and docosahexaenoic acid
(EPA+DHA) correlates inversely with adverse cardiovas-
cular outcomes and is proposed as a cardiovascular risk
factor (Omega-3 Index) (Harris & von Schacky, 2004) on
the premise that it reflects the composition of the
myocardium. However, animal tissues vary in omega-3
content and balance.
Objectives: To establish the relationships between EPA
+DHA in human RBC, atria and ventricle.
Methods: This study evaluated the fatty acid composition of
right atria and left ventricles from fresh donor hearts available
through a heart transplant program (n=20) and from right
atrial biopsy and red blood cells, obtained during cardiac
surgery (n=10).
Results: DHA was the major omega-3 fatty acid in all
tissues. Patterns of incorporation were different in different
tissue types. No differences were seen between biopsy
samples of right atria and donor right atria. EPA+DHA was
highly correlated between RBC and right atria biopsy (r
2=
0.6, P=0.0001) and between right atria donor and left
ventricle donor (r
2=0.7, P<0.0001).
EPA DHA EPA+DHA
RBC *1.15±0.58 5.59±1.42 *6.74±1.69
Right atria biopsy 0.58±0.71 5.12±2.11 5.71±2.68
Right atria donor 0.75±0.35 5.93±2.11 6.70±2.40
Left ventricle donor 0.77±0.38 **4.51±1.22 **5.28±1.55
Data are mean±SD. *P<0.05 v right atria biopsy; **P<0.0001 v right
atria donor; paired t-test.
Conclusions: Having established there was no difference in
the levels of omega-3 EPA+DHA in right atrial samples
betweenstudygroups,weconcludethatEPA+DHA inhuman
red blood cells is a valid marker of ventricular EPA+DHA.
TTA is a Pan PPAR Ligand which Markedly Stimulates
Fatty Acid Oxidation Following In Vivo Administration
Ahmed M. Khalid
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Peroxisome proliferator-activated receptor a (PPARa) is
known to be important in long term regulation of fatty acid
(FA) oxidation in the heart. Most studies, however, have
shown little effect of PPARα agonists on myocardial PPAR
target genes or cardiac FA oxidation when administered in
vivo. In the present study we examined metabolic effects of
tetradecylthioacetic acid (TTA, a pan PPAR agonist) on
hearts from Balb/c mice. The animals were treated for
8 days (TTA 0.5%, added to the diet), after which
myocardial FA and glucose oxidation, myocardial oxygen
consumption (MVO2) and cardiac work (pressure-volume
area, PVA) were measured using the isolated working heart
model. Changes in cardiac gene expression were measured
with RT-PCR.
TTA treatment resulted in a near 2.5 fold increase in
myocardial FA oxidation with a concomitant -47% reduc-
tion in glucose oxidation. This change in cardiac metabo-
lism occurred in the face of a significant reduction in
circulating plasma lipids. Hearts from TTA-treated mice
also showed a marked reduction in cardiac efficiency (97%
increase of unloaded MVO2, as deduced from the y-
intercept of the extrapolated MVO2:PVA relationship).
The gene expression analysis showed upregulation of
PPARα target genes, including mcpt1, cte1, pdk4 and
ucp3. The stimulatory effect of TTA on cardiac FA
oxidation was not found in TTA-treated PPARα KO mice.
In conclusion, TTA is a potent transcriptional activator of
142 Cardiovasc Drugs Ther (2008) 22:133–158PPARα in the heart, that markedly increases myocardial FA
oxidation.
The Intrinsic Circadian Clock Within the Cardiomyocyte
Directly Regulates Myocardial Gene Expression,
Metabolism, and Contractile Function
Molly S. Bray, Chad A. Shaw, Michael W.S. Moore,
Rodrigo A. P. Garcia, Melissa M. Zanquetta, Ju-Yun Tsai,
Jason R. B. Dyck, Chi-Wing Chow and Martin E. Young.
USDA/ARS Children’s Nutrition Research Center, Baylor
College of Medicine, Houston, Texas, 77030, USA.
Background - Virtually every mammalian cell, including
cardiomyocytes, possesses an intrinsic circadian clock. The
role of this transcriptionally-based molecular mechanism in
cardiovascular biology remains unknown.
Hypothesis - We hypothesized that circadian clock within
the cardiomyocyte plays a role in regulating myocardial
metabolism and contractile function.
Methods and Results – To study the role of circadian
clock within the heart, we generated a cardiomyocyte-
specific circadian clock mutant (CCM) mouse. Through
microarray analysis, we identified 1155 and 362 clock-
regulated genes in atria and ventricles, respectively. These
genes cluster into 5 major categories: regulation of
transcription, transport, signal transduction, protein turn-
over, and metabolism. In addition, we observed circadian
rhythms in cardiac power and efficiency in wild-type hearts
ex vivo, which were abolished in CCM hearts. Moreover,
myocardial oxygen consumption and fatty acid oxidation
rates were increased, and heart rate was reduced in CCM
hearts. Furthermore, CCM hearts demonstrated a loss of
circadian rhythms in metabolic and functional responses to
a workload challenge normally observed in wild-type hearts
ex vivo.
Conclusions - These studies identify roles for the circadian
clock within the cardiomyocyte, exposing direct influences
on myocardial gene expression, metabolism, contractile
function, and anticipation of workload changes.
The Disastrous Effects of 8 Weeks of Overindulgence
B. Huisamen, D. Dietrich, S. Genade, A. Lochner
Dept. Biomedical Sciences, Faculty of Health Sciences,
University of Stellenbosch, Tygerberg, 7505 (bh3@sun.ac.za)
Background: Cardiovascular mortality is increased among
persons with diabetes, and the incidence of heart failure,
following a myocardial infarction is much greater among
diabetic than non-diabetic patients. According to MRC
predictions, the incidence of obesity is currently nearly 60%
in some population groups in South Africa, foreshadowing
an elevation in type 2 diabetes prevalence.
Aim and methods: We studied the effects of altered diet on
myocardial function, using a rat model of hyperphagia
(DIO=diet supplemented with sucrose and condensed milk
for 8 weeks) compared to age-matched control animals.
Afterwards, isolated perfused hearts were subjected to
ischaemia/ reperfusion and infarct size determination by
TTC staining. Fasting blood glucose, insulin and homo-
cysteine levels and body weight were recorded.
Results: Body weights of DIO animals were significantly
increased after 8 weeks on diet (396.1±7.9 vs 358.2±5.1
gm, p=0.0006, n=12) and their fasting blood glucose
levels significantly elevated (4.65±0.2 vs 3.78±0.1 p=
0.003, n=8). Baseline mechanical function was identical in
both groups. However postischaemic functional recovery
was significantly lower in DIO animals than in controls
(41.9% recovery vs 57.9%; p<0.05, n=7–11). Surprisingly,
hearts from the DIO animals presented with significantly
smaller infarct size (17.55±1.8%, p=0.005, n=8) than
controls (35.44±6.5% of the area at risk, n=7) after regional
ischaemia.
Conclusion: 8 weeks of DIO resulted in weight gain and
elevated blood glucose levels. In conjunction with this,
hearts showed curtailed functional recovery after global
ischaemia but smaller infarct size after regional ischaemia
indicating defects in contractility but probably not in
survival pathways.
‘Western’ Diet, but not High Fat Diet, Causes
Maladaptation of Cardiac Fatty Acid Metabolism and
Cardiac Dysfunction in the Wistar Rat
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Obesity and diabetes are associated with increased fatty
acid availability in excess of fatty acid oxidation capacity.
This mismatch is implicated in the pathogenesis of cardiac
contractile dysfunction. We tested the hypothesis that a
“western” or a high fat diet will lead to maladaptation of
cardiac fatty acid oxidation and subsequent contractile
Cardiovasc Drugs Ther (2008) 22:133–158 143 143dysfunction. Male Wistar rats (n=12–17/group) were fed a
control, western, or high fat (10%, 45%, or 60% calories
from fat, respectively) diet for acute (1 day and 1 week),
short (1–2 months), intermediate (4–6 months), or long (8–
12 months) term. In one set of rats, cardiac power, glucose
oxidation and oleate oxidation were assessed in isolated
working hearts. In parallel experiments, hearts were
isolated for quantitative RT-PCR mRNA transcript analysis.
Cardiac power decreased with the western diet (-24%, p<
0.05). There was no significant decrease in cardiac power
with the high fat diet. Oleate oxidation was increased with
western diet in the acute (+17%), short (+36%) and
intermediate term (+31%) (p<0.01), but not in the long
term. In contrast, oleate oxidation was increased with the
high fat diet at all time points investigated (+38%, +44%,
+62%, and +15% for acute, short, intermediate, and long
term, respectively; p<0.05). There was a sustained decrease
in glucose oxidation with western diet by 38% (p<0.05)
which was coincident with a sustained induction of the
mRNA encoding for pyruvate dehydrogenase kinase 4
(PDK4) by 68% (p<0.01). Glucose oxidation was similarly
decreased with high fat diet by 42% (p<0.05), which was
coincident with a sustained induction of the mRNA
encoding for PDK4 by 266% (p<0.01). mRNA transcripts
for genes involved in fatty acid-mediated futile cycling, such
as cytosolic thioesterase 1 (CTE-1), were upregulated to a
greater extent by the high fat diet (CTE-1 average +551%,
p<0.001), as compared to the western diet (CTE-1 average
+296%, p<0.001). In conclusion, a greater activation of
oleate oxidation and PPARα-regulated gene expression in
the hearts of rats fed a high fat diet, as compared to a western
diet, is coincident with maintenance of cardiac function. This
implicates inadequate activation of PPARα with the western
diet in the development of cardiac dysfunction.
Metabolic Fluxes Quantitated from Pre-steady-state
Single-time-point NMR Spectra of Mammalian Tissue
Samples
Johannes HGM van Beek, Johan Groeneveld, David JC
Alders and Thomas Binsl
Centre for Integrative BioInformatics and Centre for
Medical Systems Biology, VU University Amsterdam, the
Netherlands
In this study metabolic fluxes in porcine heart in vivo are
quantitated with a computational model for stable isotope
distribution in the metabolic network. The experimental
protocol entails exactly 5.5 min infusion in a coronary artery
of carbon-13 enriched acetate which is metabolized in the
TCA cycle. At the end of infusion, tissue samples from the
heart are quickly frozen, extracted and carbon-13 NMR
spectra determined. Flux parameters are estimated from the
NMR multiplet intensities. Flux parameter optimization with
the metabolic model for the TCA cycle and communicating
amino acid pools yields 4 metabolic fluxes. The feasibility of
flux quantitation and the optimal infusion time were
demonstrated by computer simulations. Flux values were
tested against ‘gold standard’ measurements of O2 consump-
tion (VO2). TCA cycle flux was quantified in absolute terms
(mean±SD: 7.7±3.0 μmol/g dry weight/min, 60 samples
from 7 normal pig hearts in situ) and agreed with the flux
calculated by dividing VO2 by the stoichiometric ratio. NMR
and O2 measurements on hearts in situ (n=42) showed
excellent correspondence (r=0.88) over a broad range of
conditions (baseline, dobutamine stress, ischemia, coronary
vasodilation, lipopolysaccharide). The relation between local
TCA cycle flux and blood flow was determined under all
conditions. The linear relation between blood flow and TCA
cycle flux explains 43% of blood flow variance in normal
heart. At 870 μM coronary venous acetate concentration,
acetate delivers 58% of acetyl CoA taken up in the TCA
cycle. This method makes it possible to quantitate fluxes in
myocardial metabolic networks in vivo.
Computational Model Analysis Of Dynamic Adaptation
of Myocardial Oxidative Phosphorylation
Johannes HGM van Beek
Centre for Integrative BioInformatics and Centre for Medical
Systems Biology, VU University Amsterdam, the Netherlands
Cardiac workload fluctuates perpetuously and myocardial
ATP synthesis adapts. A computational ‘skeleton model’ is
analyzed for the first phase of dynamic adaptation of
myocardial oxidative phosphorylation (OxPhos). This mod-
el centers on adenine nucleotides, creatine and phosphate
groups. Well-known parameter values are included for the
enzyme kinetics from cytoplasmic and mitochondrially
located creatine kinase isoforms studied in isolation. The
hotly debated mitochondrial outer membrane (MOM)
permeability was estimated, using the model, from the
dynamic response time of OxPhos (tmito; generalized time
constant) to jumps in cardiac pacing rate. The experimen-
tally determined tmito is 3.7 s at the level of the
mitochondria in rabbit heart with inhibited glycolysis and
is reproduced with MOM permeability optimized to 21 μm
s
-1 in the model. This value determined in vivo is about four
times higher and four times lower, respectively, than the
conflicting permeability values resulting from two different
in vitro approaches, both incompatible with the measured
tmito. The latter permeability values were compatible with
ADP concentrations required for 50% stimulation of the
144 Cardiovasc Drugs Ther (2008) 22:133–158mitochondria (KADP) of about 20 and 250 μM. KADP is
therefore predicted to be about 70 μM in vivo. The model
predicts correctly that a lower tmito is measured if CK
activity is inhibited by 98%. The model predicts further that
myocardial ATP synthesis shows substantial pulsatility, that
OxPhos reacts slower if CK in the cytoplasm is overex-
pressed and faster if mitochondrial CK is overexpressed.
About one third of the transport of ‘high energy’ phospho-
ryl groups in rabbit cardiomyocytes is via phosphocreatine.
TIME-Resolved Analysis of NAD(P)H in Living Cardiac
Cells: The Effect of 4-Hydroxynonenal (HNE)
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NAD(P)H plays a crucial rolein the management ofoxidative
metabolism as the principal electron donor for enzymatic
reactions and a major source of autofluorescence induced
following excitation by UV light. Screening fluorescence
dynamics of intrinsic cellular autofluorescence is a powerful
tool to investigate cardiomyocyte metabolic and oxidative
properties. Our aim is to develop a new approach of high-
content analysis of NAD(P)H autofluorescence assessing
oxidative metabolic changes in living cardiomyocytes and
testing the cellular NAD(P)H responses to HNE,an important
by-product of lipid peroxidation. Spectrally-resolved time-
correlated single photon counting (TCSPC) was used to
measure NAD(P)H fluorescence spectra and fluorescence
lifetimes following excitation by a pulsed picosecond 375 nm
laser diode. Freshly isolated living cardiomyocytes were
treated with HNE in the presence or absence of a glutathione
reductase blocker, or of complex I and IV respiratory chain
inhibitors. In agreement with the capacity of HNE to decrease
NADPH production by inhibiting NADP-isocitrate dehydro-
genase, treated cardiomyocytes presented a loss of NAD(P)H
autofluorescence, accompanied by a slight red spectral
broadening. Our data uncovered implication of the enzymes
of the respiratory chain in the HNE action; results in contrast
with effects of H2O2, a common oxidative agent, point to
implication of different metabolic pathways.
Our findings indicate that spectrally-resolved TCSPC is a
powerful tool for quantitative high content assays of NAD(P)
H molecules in living cardiomyocytes. It can be particularly
usefulforunderstandingtheroleofmitochondrialmetabolism
and oxidative stress in the development of cardiac diseases.
Supported by the Canadian Institutes for Health Research.
AMPK-mediated Increase in Myocardial Long-Chain
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CD36, also named fatty acid translocase, has been
identified as a putative membrane transporter for long-
chain fatty acids (LCFA). In the heart, contraction regulates
cellular LCFA uptake through translocation of CD36 and
possibly of other LCFA transporters from intracellular
storage compartments to the sarcolemma. This regulation
is mediated by contraction-induced 5’ AMP-activated
protein kinase (AMPK) signaling. In this study isolated
cardiac myocytes from CD36
+/+ and CD36
-/- mice were
used to investigate to what extent basal and AMPK-
mediated LCFA uptake are CD36-dependent.
Basal LCFA uptake was not altered in CD36
-/- mice, likely
because of a (1.8-fold) compensatory upregulation of
fatty acid transport protein-1. The CD36 inhibitor sulfo-
N-succinimidylpalmitate reduced basal LCFA uptake into
cardiac myocytes from CD36
+/+ mice by 38%, while not
affecting cardiac myocytes from CD36
-/- mice. Oligomycin
and dipyridamole, two contraction-like stimuli, increased
LCFA uptake into cardiac myocytes from CD36
+/+ mice by
2.5- and 1.6-fold, respectively. In contrast, in cardiac
myocytes from CD36
-/- mice, oligomycin and dipyridamole
increased LCFA uptake only by 1.3- and 1.1-fold, respective-
ly, despite the fact that AMPK signaling in these cardiac
myocytes was fully intact. Glucose uptake was not different
between cardiac myocytes from CD36
+/+ and CD36
-/- mice
under basal conditions nor in the presence of oligomycin or
dipyridamole.
We conclude that CD36 is almost entirely responsible for
the AMPK-mediated increase of LCFA uptake, indicating a
pivotal role for CD36 in mediating changes in cardiac
LCFA fluxes.
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Cardiac myocytesneed a constantsupplyof energy. The main
cardiac energy substrates are fatty acids (FA) and glucose.
Their uptake occurs in a regulated process, involving several
transport proteins (GLUT1 and GLUT4 for glucose, and
CD36 and several other FA-binding proteins for FA) and
signal transduction cascades (insulin signaling, AMPK
signaling, etc). For both GLUT4 and CD36, activation of
signal transduction cascades results in translocation from an
intracellular pool to the sarcolemma, where the transporters
increase the rate of substrate uptake.
Type 2 diabetes mellitus (DM2) leads to altered energy
substrate utilization. DM2 is characterized by insulin
resistance, increased FA utilization and a permanent
relocation of CD36 to the sarcolemma.
We aim at studying the early onset of DM2 in a suitable
model system. Cultures of adult primary rat cardiac
myocytes have many characteristics making them a good
model system. Upon isolation these cells have the pheno-
type of the cells of interest, while in culture the environ-
ment can be controlled. Cultured cells can be electrically
stimulated to controlled contractions and can be infected
with modified viruses to manipulate the expression of
selected proteins. On the other hand, because the cells do
not divide, studies are limited to several days due to cell
losses and adaptation resulting in changes at the morpho-
logical and metabolic level.
Preliminary data on the short-term culturing of adult
primary rat cardiac myocytes will be presented.
Supported by the Netherlands Organization for Health
Research and Development (NWO-ZonMw grant 40–
00812–98–03075)
RAB11a is Short-time Activated by Insulin and Regulates
the Internalization of GLUT4 and FAT/CD36 Containing
Vesicles
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As a member of the Rab small GTPase family, Rab11a has
been shown to be involved in different vesicle trafficking
processes. In earlier work we identified Rab11a to be present
in GLUT4 and in FAT/CD36 containing vesicles, with an
increase in GLUT4 containing vesicles after insulin stimula-
tion. However, it remained elusive if Rab11a is directly
activated by the insulin signalling cascade and at which step a
potential activation occurs. To examine the GTP-loading of
Rab11a, we introduced a biotinylated GTP-analog into H9c2-
hIR cells, transiently overexpressing HA-tagged Rab11a, and
measured its binding to the GTPase after insulin stimulation.
We observed that Rab11a is transiently GTP-loaded after
insulin stimulation. The activation of Rab11a is PI3K
dependent and downstream of Akt, as shown by in vitro
knockdown of this kinase. To further specify the functional
role of Rab11a in vesicle movement of GLUT4 and FAT/
CD36 we knocked down gene expression of Rab11a and two
of its effectors, Rip11 and FIP2, by small interfering RNAs
(siRNAs) and measured translocation of GLUT4myc and
FAT/CD36. We observed that by knocking down Rab11a
GLUT4myc- and FAT/CD36-translocation is increased as
well in the basal as in the insulin (for GLUT4) and sorbitol
(for FAT/CD36) stimulated state. In the case of GLUT4myc
the in vitro knockdown of FIP2 increased the translocation
even stronger than the Rab11a knockdown, whereas Rip11
knockdown had no effect. The FAT/CD36-translocation is
slightly increased after Rip11 knockdown and to a larger
amount after FIP2 knockdown, but not as strong as after
Rab11a gene repression. In bothvesicle populations the effect
of the stimulus on translocation is not altered after gene
knockdown of Rab11a.
These data therefore show that (i) Rab11a is directly activated
by insulin and represents an element of the PI3K signalling
cascade, (ii) Rab11a regulates the endocytosis of both,
GLUT4 and FAT/CD36 containing vesicles, (iii) the regula-
tion of GLUT4 endocytosis by Rab11a is carried out in
complex with Rab11-FIP2 and differently to FAT/CD36.
Supported by the Ministerium für Wissenschaft und
Forschung des Landes Nordrhein-Westfalen, the Bundesmi-
nisterium für Gesundheit and European Union COST
Action B17.
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146 Cardiovasc Drugs Ther (2008) 22:133–158Background: The human heart recycles ∼ 35 kg of ATP in
a single day. Thus, cardiac metabolism is emerging as a
target for the treatment of heart failure, and mitochondrial
dysfunction is becoming implicated in heart disease.
Hypothesis/objectives: Oscillatory electric fields induce
membrane proteins to change conformation leading to
nonlinear responses of charged residues and ions, which
resultsinthegenerationofharmonicsthatcanbepickedupby
sensing electrodes. Our objectives are to develop and study
electromagnetic methods [1] that probe metabolic activity of
enzyme complexes in mitochondria, the cellular plasma
membrane, and other internal membranes.
Methods: We measure 2
nd and higher degree harmonics
generated by whole cells, mitochondria, and chloroplasts, in
response to AC electric fields at frequencies ranging up to a
few ten’so fk i l o h e r t z .
Results: The measured harmonics depend strongly on
frequency, field amplitude, and metabolic activity, as shown
in Fig. 1. In the case of mitochondrial suspensions, electron
transport chain (ETC) activators and inhibitors affect
observed features in 2
nd harmonic spectra.
Harmonic generation spectra of suspensions of budding
yeast (S. cerevisiae, top), a relative of the mitochondrial
ancestor (B. indicas, lower left), and uncoupled mammalian
mitochondria, in which ETC complexes I, III, and IV have
been activated by adding glutamate malate (lower right).
The spectral features generated by S. cerevisiae are observed
to increase with cell concentration (upper left). We find that
potassium cyanide, which binds to complex IV and com-
pletely shuts down ATP production, suppresses the observed
spectral features, as seen in the B. indicas data. The higher
frequency feature (∼12 kHz) observed in whole cells is not
seen in uncoupled mitochondria, where ATP synthase is
inactive. The data was obtained with the 4-electrode setup, in
which a sinusoidal voltage is applied across the outer two
electrodes and the induced harmonics are measured across
two inner electrodes with a spectrum analyzer.
Conclusions: Harmonic generation spectroscopy reflects
mitochondrial ETC function in live cells, and provides a
technique to assess mitochondrial function in human
tissues. A possible application includes assessment of
myocardial mitochondria in patients with heart failure and
diabetes. We are also exploring methods to electromagnet-
ically probe enzyme activity at the nanoscale.
[1] Miller, JH, Jr. et al. Electromagnetic probes of molecular motors in
the electron transport chains of mitochondria and chloroplasts. Jd e
Physique IV France, 2005;131:363–366.
TGF-β and 12-Lipoxygenase Regulate Glut4 Expression
in Cardiac Cells
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We have recently shown that eicosanoids participate in the
regulation of cardiac glucose transport and GLUT4 trans-
location. In the present study we investigated the role of
12-lipoxygenase (12-LO) in the regulation of glucose trans-
porter 4 (GLUT4) expression and its translocation to the
plasma membrane in a cardiac cell system. We established a
robust gene knock down of 12-LO by siRNA in H9c2-hIR
cells. After siRNA treatment for 48h we could downregulate
12-LO protein expression to 30±5% (p<0.001) and mRNA
expression to 10±4% (p<0.01). In addition, treatment with
baicalein, a 12-LO specific inhibitor, decreased 12-LO
protein levels to 40±5% (p<0.05).
Generation of 12(S)-hydroxyeicosatetraenoic acid (HETE),
a 12-LO specific product and inflammatory mediator, was
affected by 12-LO abundance as measured with a HETE
ELISA (n=5). After siRNA mediated gene knockdown of
12-LO (si 12-LO), HETE expression was reduced to 50±
10% (p<0.001) normalized to incubation with non coding
siRNA (nc siRNA). 12-LO inhibition decreased HETE to
55±15% (p<0.05) in comparison to untreated cells (uc).
Compared to this data HETE generation was significantly
increased after 12-LO activation by TGF-β (144±10%; p<
0.05) or high glucose (125±15%; p<0.05) over night.
However, TGF-β could not increase HETE generation after
gene knockdown of 12-LO (75±5%; p<0.05) compared to
nc siRNA.
In a parallel approach we overexpressed a myc epitope-
tagged GLUT4. GLUT4 protein expression was significantly
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cells in comparison to transfection with nc siRNA. This
effect was 12-LO specific, because transfection with siAkt
(90% knockdown), does not change GLUT4 protein
expression compared to nc siRNA. 12-LO downregulation
also affected GLUT4 mRNA expression in accordance with
our results at the protein level. Consistent to these findings,
an incubation with TGF–β over night down regulated
GLUT4 protein expression in uc and nc siRNA transfected
cells. However, when silencing 12-LO, the effect of TGF-β
on GLUT4 protein expression was no more detectable (p<
0.05). In H9c2-hIR cells overexpressing GLUT4, 2-DOG
uptake and GLUT4 translocation can be stimulated by
insulin up to 150±10% (p<0.001) and 170±15% (p<
0.001), respectively. 12 – LO knock down totally abolished
insulin stimulated 2-DOG uptake (p>0.05), despite higher
GLUT4 expression. Accordingly insulin - stimulated
GLUT4 translocation to the plasma membrane was com-
pletely inhibited after 12 – LO downregulation (p>0.05).
In conclusion eicosanoids appear to be regulators of
GLUT4 expression and it might be hypothesized that
increased eicosanoid levels during inflammation may
cause GLUT4 down regulation. We demonstrated that
12-LO repression causes a defect in insulin - induced
translocation of GLUT4 to the plasma membrane and 2-
DOG uptake. This can possibly be attributed to a loss in
HETE production and thereby a destabilisation of the
cytoskeleton. (This work was supported by German Israel
Foundation)
Insulin Induces Reversible Translocation of CD36 to
the Plasma Membrane in Cho Cells: a Morphological
Characterization
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In cardiac and skeletal muscle, long-chain fatty acid
(LCFA) uptake is regulated by insulin via the putative
LCFA transporter CD36. Biochemical studies propose an
insulin-induced translocation of CD36 from intracellular,
endosomal pools to the plasma membrane (PM), similar to
translocation of glucose transporter 4 (GLUT4). To mor-
phologically characterize insulin-induced CD36 transloca-
tion, we developed Chinese hamster ovary (CHO) cells
stably expressing rat CD36 (CHO-CD36). Using immuno-
fluorescence microscopy, CD36 was found both intracellu-
larly - in (at least partially) different compartments than
GLUT4 - and at the PM, and translocated to the PM upon
insulin incubation, as did myc-tagged GLUT4 (GLUT4-
myc). The insulin-induced increase in cell surface CD36
content was confirmed and quantified by surface-protein
biotinylation (1.7-fold increase). Moreover, insulin-induced
CD36 translocation was wortmannin-sensitive (i.e. phos-
phatidylinositol-3 kinase-dependent), and reversible (30–60
minutes after insulin wash-out). Hence, insulin-induced
CD36 translocation in CHO cells closely resembles the
proposed physiological process in skeletal muscle and
heart. Whereas the insulin-induced increase in PM GLUT4-
myc correlates with an increased [
3H]deoxyglucose uptake
into CHO cells, the increase in PM CD36 content was not
paralleled by a change in [
14C]palmitate uptake, suggesting
that additional proteins or a protein activation step are
needed. Taken together, this study presents the first
morphological evidence for CD36 translocation, and advo-
cates CHO-CD36 cells as an adequate model system to
further characterize this process.
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Aim Membrane fatty acid transporters can modulate the
balance between fatty acid uptake and subsequent storage
and/or oxidation in muscle tissue. As such, skeletal muscle
fatty acid transporter protein expression could play an
important role in the etiology of insulin resistance and/or
type 2 diabetes.
Methods In the present study fatty acid translocase (FAT/
CD36), plasma membrane-bound fatty acid-binding protein
(FABPpm) and fatty acid transport protein 1 (FATP1)
mRNA and protein expression were assessed in muscle
148 Cardiovasc Drugs Ther (2008) 22:133–158tissue obtained from 10 sedentary, overweight type 2
diabetes patients (60±2 yrs), 10 sedentary, weight-matched
normoglycemic controls (60±2 yrs) and 10 age-matched,
endurance trained cyclists (57±1 yrs).
Results Both FAT/CD36 and FATP1 mRNA and protein
expression did not differ between groups. In contrast,
FABPpm mRNA and protein expression were ∼30–40%
higher in the trained men compared to the diabetes patients
(P<0.01) and sedentary controls (P<0.05).
Conclusions Skeletal muscle FAT/CD36, FABPpm and
FATP1 mRNA and protein expression are not up- or down
regulated in a sedentary and/or insulin resistant state. In
contrast, FABPpm expression is upregulated in the endur-
ance trained state and likely instrumental to allow greater
fatty acid oxidation rates.
Characterizing the PPARα Dependent Transcriptome
in Murine Heart
Anastasia Georgiadi, Michael Müller, Sander Kersten
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The peroxisome proliferators-activated receptor alpha is a
ligand activated transcription factor activated by a variety
of fatty acids and lipophilic compounds. Studies in liver
have revealed that PPARα governs a variety of metabolic
processes, including fatty acid catabolism and inflamma-
tion. Although PPARα is expressed at high levels in the
heart, there is little knowledge on the type of pathways that
are under control of PPARα in heart.
The aim of our study is to provide a global overview of
genes regulated by PPARα in the heart. For that purpose we
used a highly specific PPARα synthetic ligand Wy14643.
Wildtype and PPARα
-/- mice were fed a diet supplemented
with 0.1% Wy14643, for 5 days. Total RNA from heart was
hybridized on Affymetrix NuGO customized arrays. Nor-
malization was performed by GC-RMA and differentially
expressed transcripts were selected based on fold-change
cutoff. Pathway analysis tools were utilized to identify
metabolic processes regulated by Wy14643.
Five days feeding with Wy14643 increased the expression
of 339 genes and decreased the expression of 302 genes,
none of which were altered in PPARα
-/- mice. Pathways
analysis revealed that various fatty acid metabolic pathways
were under control of PPARα.
In conclusion, we show by microarray analysis that
PPARα plays an important role in the regulation of fatty
acid metabolism in heart. A more in depth analysis of
pathways regulated by PPARα and of the effect of
dietary fatty acid on global cardiac gene expression is
ongoing.
Supported by the European-Marie Curie project ‘NucSys’.
Upregulation of Lipoprotein Secretion: A Mechanism
to Maintain Myocardial Lipid Homeostasis in
Cardiomyocyte-restricted PPARδ Knockout Mice?
Qinglin Yang, Qianhong Qin, Jian Liu, Yuquan Li,
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Dept. of Biochemistry, Cardiovascular Research Institute,
Morehouse School of Medicine, Atlanta GA, USA
Peroxisome proliferator-activated receptors are nuclear hor-
mone receptors and ligand-activated transcription factor
controlling lipid and carbohydrate metabolisms. All three
subtypes of PPARs, PPARα, γ and δ are expressed in the
heart.Theymayserveaskeydeterminantsofmyocardialfatty
acid metabolism. We previously demonstrated that PPARδ is
required for normal expression of series essential enzymes
that govern myocardial fatty acid oxidation (FAO). Cardio-
myocyte-restricted PPARδ knockout in mice (CR-PPARδ
-/-)
shows depressed myocardial FAO and bioenergetics, leading
to dilated cardiomyopathy with myocardial lipid accumula-
tion at the end stage hearts. It remains unclear why
myocardial triglyceride content is largely normal in young
adult CR-PPARδ
-/- hearts, despite a depressed myocardial
FAO rate. We further investigate lipid uptake and lipoprotein
secretion pathways in the mouse hearts of the cardiomyo-
cyte-restricted PPARδ knockout mice. Using Quantitative
real-time PCR (QPCR), we discovered that transcript levels
of genes encoding major fatty acid uptake proteins such as
CD36, fatty acid transport protein-1, fatty acid biding
protein, were downregulated by about 33, 46 and 50%,
respectively, in CR-PPARδ
-/- hearts compared with con-
trolled hearts. Interestingly, the protein expression levels of
these fatty acid uptake proteins were not correspondingly
decreased in the adult CR-PPARδ
-/- hearts. Since lipoprotein
mediated triglyceride secretion from cardiomyocytes may
play a role in maintaining myocardial lipid homeostasis, we
further assessed transcript expression levels of genes encod-
ing proteins that are crucial for lipoprotein secretion from
cardiomyocytes. QPCR revealed that the expression levels of
Microsomal triglyceride transfer protein (MTP), the protein
required to add lipid to apolipoprotein B (ApoB), were
attenuated about 36% in CR-PPARδ
-/- hearts compared with
controls, whereas the expression levels of apoB transcript
were increased over 10 fold in CR-PPARδ
-/- hearts. The
corresponding protein levels of apoB were substantially
increased in CR-PPARδ
-/- hearts compared with controls.
Despite the downregulation of MTP transcritp, MTP activities
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-/- hearts compared
to controls. These results implicate that CR-PPARδ
-/- hearts
maintain relative myocardial lipid homeostasis via upregu-
lating apoB expression and MTP activities to increase
lipoprotein secretion, thus helping the young CR-PPARδ
-/-
hearts to avoid early accumulation of neutral lipid.
PDK1, but not PKB, is Required for the Activation
of the Mtor/P70s6k Pathway by Leucine in the Heart
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Background: Insulin regulates the mammalian target of
rapamycine/p70 S6 ribosomal protein kinase (mTOR/
p70S6K) pathway through a canonical signalling pathway that
includes the phosphoinositide-dependent protein kinase 1/
protein kinase B (PDK1/PKB) axis. Currently, the mechanism
of amino acid input integrated with that of the insulin
signalling pathway is unclear.
Aim: We examined signalling events that activate p70S6K
in response to insulin and amino acids in the adult heart.
Methods: Hearts from adult wild-type (WT) and cardio-
specific PDK1 knock-out (KO) mice were isolated and
perfused by the Langhendorff method in normoxic conditions.
Results: In WT hearts, insulin and leucine significantly
increased p70S6K activity (from 1.31±0.35 mU/mg prot to
7.84±0.94 and 4.52±1.03 mU/mg prot, respectively). By
contrast, glutamine inhibited p70S6K activity both in the
absence (0.59±0.22 mU/mg prot, p<0.05) and in presence
of insulin (3.39±0.58 mU/mg prot, p<0.05). Moreover,
insulin and leucine but not glutamine induced mTOR
phosphorylation in WT hearts. As expected, insulin
activated PKB (1.89±0.34 vs. 0.74±0.08 mU/mg prot in
control heart, p<0.05). Nevertheless, neither leucine nor
glutamine was able to activate PKB. In PDK1 KO mice, the
insulin and leucine effect on p70S6K activity and mTOR
phosphorylation was abolished. The insulin- and leucine-
induced p70S6K activation was differentially affected by
use of the PI3K inhibitors: wortmannin and LY294002,
suggesting the implication of different class of PI3K.
Conclusion: In contrast to insulin, leucine activates p70S6K
via a PI3K-like/PDK1/mTOR-dependent but PKB-independent
pathway.
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Background. Contraction of vascular smooth muscle can be
initiated by a number of stimuli inducing a rise in intracellular
calcium and the subsequent stimulation of myosin light chain
kinase (MLCK) activity, which, in turn, phosphorylates myosin
light chain (MLC). The MLCK is also regulated by phosphor-
ylation leading to modification of K0.5 for Ca
++ or Vmax values.
Hypothesis. This study showed that MLCK was a new
substrate for p38 mitogen-activated protein kinase (p38)
and for AMP-activated protein kinase (AMPK). We tested
the hypothesis that both kinases would be key regulators of
MLCK in vascular smooth muscle (VSM).
Methods and Results. In vitro phosphorylation of chicken
gizzardpurifiedMLCKbyrecombinantAMPKallowedusto
identifyonephosphorylationsitelocatedintheC-terminalCa
++/calmodulin domain of MLCK. This phosphorylation led
to an increased K0.5 for Ca
++.B yc o n t r a s t ,M L C K
phosphorylation by p38 resulted in an increased Vmax due
another phosphorylation site. Interestingly, phosphorylation
at both sites resulted in MLCK activation suggesting the
inhibitory effect of the AMPK site is blunted by the p38
phosphorylation site. In primary cultures of VSM cells,
AMPK and p38 were activated in response to vasoconstric-
tors within the same time. When the AMPK pathway was
inhibited using specific inhibitors, p38 was over activated.
Conclusion. We proposed that AMPK negatively regulates
p38 and MLCK in vascular smooth muscle. Results
obtained with alpha-1 knockout mice support this conclu-
sion and will be presented at the meeting.
Regulation of Glucose Uptake in Cardiomyocytes by
Amp-activated Protein Kinase
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rics and Pharmacology, University of Alberta, Canada
150 Cardiovasc Drugs Ther (2008) 22:133–158Glucose uptake and glycolysis in the heart are increased
during myocardial ischemia in order to provide an
additional anaerobic source of ATP for the heart. This
alteration in glucose metabolism constitutes an important
contributing factor towards ischemic injury, and therefore it
is important to understand how glucose uptake is controlled
in the ischemic heart. There are primarily two glucose
transporters which regulate glucose uptake into cardiac
myocytes, GLUT1 and GLUT4. In the non-ischemic heart,
insulin is only able to stimulate the translocation of GLUT4
to the sarcolemmal membrane, while both GLUT1 and
GLUT4 translocation can occur following AMPK stimula-
tion. Using a newly developed technique involving [
3H]2-
deoxyglucose, we measured glucose uptake in the H9c2 rat
cardiomyocyte cell line, and demonstrate that while insulin
has no detectable effect on glucose uptake, AMPK
stimulation by phenformin results in a 2.5-fold increase in
glucose uptake. Furthermore, Insulin treatment produced no
discernible effect on either phospho-Akt or phospho-
AMPK intracellular protein levels, while treatment with
phenformin results in an increase in phospho-AMPK, and a
decrease in phospho-Akt. Finally, visualization of a dsRed-
GLUT4 fusion construct in H9c2 cells by laser confocal
microscopy showed that unlike insulin, AMPK stimulation
with phenformin did not redistribute GLUT4 to the plasma
membrane, suggesting that AMPK may be regulating
glucose uptake via another glucose transporter. These
studies suggest that AMPK is a major regulator of glucose
uptake in cardiomyocytes.
UCP3 and Mitochondrial ROS Production in Cardiac
and Skeletal Muscle
Miranda Nabben
a, Joris Hoeks
a, Jan F.C. Glatz
b, Jacco J.
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c, Matthijs K.C. Hesselink
d, Patrick Schrauwen
a
Departments of
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Maastricht University;
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Background: UCP3, which is present in the inner membrane
of cardiac and skeletal muscle mitochondria, is increased
when fatty acid (FA) supply to the mitochondria exceeds FA
oxidation and is decreased in situations where fat oxidation
exceeds FA supply. Remarkably, UCP3 is downregulated in
type II diabetic patients, and pre-diabetic subjects. However,
the exact function of the protein is still unknown.
Hypothesis/objectives: Previous results suggested involve-
ment of UCP3 in the protection of mitochondria against
excessive fatty acids, thereby preventing lipid-induced
mitochondrial damage. To test this hypothesis, the effect
of UCP3 overexpression on Reactive Oxygen Species
(ROS) production was investigated.
Methods: Both cardiac and skeletal muscle mitochondria
were isolated from 23-week-old male C57Bl6 mice over-
expressing UCP3 (UCP3Tg) (n=5), and their wildtype (Wt)-
controls (n=4). ROS production was measured using
Electron Spin Resonance spectroscopy after addition of spin
trap (DMPO). Pyruvate was used as glycolytic substrate for
cardiac measurements, whereas glutamate, malate (classical
TCA-cycle complex mixture) and succinate (complex II)
with or without ADP were used in skeletal muscle.
Results: Preliminary results show a tendency to reduced
ROS production in skeletal muscle mitochondria of
UCP3Tg mice compared to their Wt-controls both with
(peak surface 44.5±8.5 vs 32.5±10.0; p=0.10) and without
ADP (AUC 22.3±6.1 vs 17.2±1.4, p=0.08). In cardiac
muscle mitochondria no difference in ROS production was
observed (12.6±3.1 vs 10.6±0.5; p=0.18).
Conclusion: These results suggest that UCP3 is able to
directly decrease ROS production in skeletal muscle
mitochondria. A reduced UCP3 level in type 2 diabetic
patients may therefore contribute to the pathogenesis of
type 2 diabetes.
Differential Effects of AMPKα2 Deletion on p70S6K
Pathway in Normoxic and Ischemic Hearts and on the
Development of Left Ventricular Hypertrophy
E. Zarrinpashneh
1, C. Beauloye
1,A .G i n i o n
1,A . - C .
Pouleur
1, X. Havaux
1, S. Horman
2, L.Hue
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3,
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1
1Division of Cardiology,
2Hormone and Metabolic research
unit, Université catholique de Louvain, Brussels, Belgium
and
3Institute Cochin, INSERM, CNRS, René Descartes
University, Paris, France.
Background. It has been suggested that AMP-activated
protein kinase (AMPK) plays a role in the control of protein
synthesis during ischemia. It remains uncertain whether
AMPK also participates in the control of protein synthesis
under normoxia or during the development of cardiac
hypertrophy.
Aim. Accordingly, we sought to evaluate the potential
contribution of AMPK to the control of protein synthesis in
these different conditions by use of AMPKα2 knock-out
(α2
-/-) mice.
Methods. The role of AMPK was tested in isolated hearts
perfused with our without insulin and submitted or not to
ischemia. The implication of AMPK in the development of
cardiac hypertrophy was tested in mice submitted to
isoproterenol injections.
Cardiovasc Drugs Ther (2008) 22:133–158 151 151Results. Under normoxia, insulin induced similar activation
of protein kinase B (PKB) and PKB-dependent phosphory-
lation of mammalian target of rapamycin (mTOR) in both
mice. By contrast, the absence of AMPKα2 caused a
significant increase of PKBmTOR mediated activation of
p70 ribosomal S6 kinase (p70S6K). By contrast, ischemia
provoked a similar decrease in insulin-induced PKB/mTOR/
p70S6KstimulationinbothWTandα2
-/- mice. To determine
whether the increase in p70S6K seen in α2
-/- influences the
development of hypertrophy, mice were submitted to isopro-
terenol. Echo-derived left ventricular (LV) mass and anterior
wall thickness increased more in α2
-/- than in WT mice.
Conclusions: Our results show that AMPKα2 plays a role
in the regulation of p70S6K activity under normoxia but
not under ischemia. Moreover, the absence of this isoform
amplifies the isoproterenol-induced LV hypertrophy.
Cardioprotective cGMP Favors Exogenous Fatty Acid
Incorporation into Triglycerides over Direct β-Oxidation
R. Khairallah
1,M . E .Y o u n g
3,B . G .A l l e n
2,G .L o p a s c h u k
4,
C. Deschepper
2, C. Des Rosiers
2
1McGill University,
2University of Montreal,
3Baylor
College of Medicine,
4University of Alberta.
While cardiac hypertrophy has been associated with a shift in
substrateselectionforenergyproductionfromfattyacids(FA)
to carbohydrates (CHO), it remains controversial whether this
shift is adaptive or maladaptive. Since enhanced cGMP
signalling can prevent hypertrophy, we hypothesized that this
cardioprotection may involve changes in substrate selection.
The present study documents the metabolic and functional
profiles of hearts from mice overexpressing a constitutively
active soluble guanylate cyclase in a cardiomyocyte-specific
manner (Tg) using ex vivo perfusion at physiological
workload with
13C-labeled substrates. Compared to non-Tg
littermates, hearts from Tg mice displayed improved
membrane integrity (38±14% lower lactate dehydrogenase
release), while sustaining normal cardiac work. These hearts
also showed a 38±9% lower contribution of exogenous FA
to acetyl-CoA formation, while CHO (both endogenous and
exogenous) contribution was similar despite a two-fold
increase in glycolytic flux. Since calculated citric acid cycle
flux, tissue malonyl-CoA (a β-oxidation inhibitor), acetyl-
CoA and free CoA levels were similar in both groups, these
observations suggested an increased contribution from an
endogenous FA source, namely triglycerides, in Tg mice hearts.
Additionally, we observed a two-fold increase in exogenous
oleate incorporation into triglycerides and a decreased (37±
13%) phosphorylated AMPK (which inhibits triglyceride
hydrolysis) in Tg hearts. Altogether, it appears that cardiopro-
tective cGMP simultaneously may promote both triglyceride
hydrolysis and synthesis in cardiomyocytes. Since we detected
no differences in the expression of key metabolic genes, the
documented changes in substrate selection with chronic
activation of cGMP signalling are likely to result from post-
transcriptional modifications. (Funded by CIHR)
Uraemic Cardiomyopathy is Characterized by Altered
Metabolic Substrate Transport
Dunja Aksentijević,* Sunil Bhandari, Anne-Marie L.
Seymour
Department of Biological Sciences, University of Hull,
*Department of Renal Medicine, Hull Royal Infirmary,
Hull, UK
Cardiac complications are the leading cause of premature
deaths in patients with chronic kidney disease (CKD). Left
ventricular hypertrophy (LVH) is a major contributing
factor in uraemic cardiomyopathy and results in significant
metabolic, cellular and molecular remodelling. Progression
of LVH can lead to the development of insulin resistance, a
common feature in CKD and heart failure.
The aim of this study was to investigate the impact of CKD
on expression of myocardial glucose and fatty acid trans-
porters (GLUT 4 insulin sensitive transporter, GLUT1 and
FAT/CD36 fatty acid transporter).Experimental uraemia
was induced surgically via a two-stage 5/6 nephrectomy
in adult male Sprague-Dawley rats.
6 weeks later, LV tissue was harvested and the expression
of ANF, GLUT 4, GLUT 1 and FAT/CD36 examined using
SDS PAGE and Western Blotting.
At this stage, uraemic animals exhibited a significant degree of
uraemia (creatinine 69±2 vs. 40±2 μmol/L n=2 7p<0.05),
hypertrophy(dryheartweight:tibialength0.5±2vs.0.3±2g/cm
n=23, p<0.05), hyperinsulinaemia (2.1±0.1 vs. 1.5±0.1 μg/L,
n=26, p<0.05), anaemia (29±1 vs. 34±1% n=20, p<0.05)
and hypertension (163±1 vs.147±2 mmHg, n=25 p<0.05).
Uraemic tissue showed a significant increase in myocardial
ANF, GLUT 4 and CD 36 expression. (Figure 1, **p<0.05
vs. control) GLUT 1 expression was unaltered.
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Therefore, 6 week uraemia is characterized by LVH,
significant haemodynamic abnormalities and altered ex-
152 Cardiovasc Drugs Ther (2008) 22:133–158pression of glucose and fatty acid transporters indicative of
developing insulin resistance, remodelling, and ultimately
heart failure.
Fatty Acid Transporters in the Hypertrophied Human
Heart: Differences Between Atria and Ventricles
Lisa C Heather
a, Neil J Howell
b, Mark A Cole
a, Michael P
Frenneaux
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b and Kieran Clarke
a
aCardiac Metabolism Research Group, Department of
Physiology, Anatomy and Genetics, University of Oxford,
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University Hospital NHS Foundation Trust, Birmingham,
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Objectives: In the failing human heart, fatty acid metabo-
lism is reduced and correlates with the severity of disease
and the degree of hypertrophy. We hypothesized that, in the
human heart, the protein levels of the fatty acid trans-
porters, fatty acid translocase (FAT/CD36), cytosolic and
plasma membrane fatty acid binding proteins (cFABP and
FABPpm) and fatty acid transport proteins (FATP) 1 and 6,
would also vary with the severity of cardiac impairment.
Methods and Results: In biopsies from 20 patients with
aortic valve disease, Western blotting revealed significant
differences in the protein levels of the fatty acid and glucose
transporters between the atrial and ventricular tissue. FAT/
CD36, FATP1, FABPpm, cFABP and GLUT4 were higher in
theventricle,whereasFATP6washigherintheatria.Intheatria,
there were positive correlations between FAT/CD36, FABPpm
and cFABP, and independently between FATP1 and 6. In the
ventricle, the relationship between FABPpm and cFABP, and
between FATP1 and 6 was still present. There was a negative
correlation between ventricular FAT/CD36 and GLUT4 protein
levels. A correlation between the fatty acid transporters, disease
severity or plasma metabolites was not detected.
Conclusions: The inverse relationship between the predom-
inant fatty acid transporter FAT/CD36 and glucose trans-
porter GLUT4 in the ventricle resembles the metabolic shift
away from fatty acid oxidation towards glucose utilisation,
which occurs in heart failure. In addition, there appears to be
different roles, or regulatory mechanisms, for the different
fatty acid transporters in human atria and ventricle.
Impact of 3 Week High-Fat Diet on Fatty Acid Metabolism
and Gene Expression in Cardiac Hypertrophy
Ashwin Akki and Anne-Marie L. Seymour,
Department of Biological Sciences, University of Hull, Hull
UK.
Impaired fatty acid (FA) oxidation in the setting of cardiac
hypertrophy (CH) can lead to inappropriate accumulation of
lipids, which may underlie deterioration into heart failure.
We investigated alterations in FA metabolism in CH in
response to high-fat feeding. CH was induced in male
Sprague–Dawley rats by abdominal aortic constriction
(AC). Group 1 received normal diet for 9 weeks post-
surgery whilst Group 2 received a high-fat diet (45% kcal
from lipids) from weeks 6 to 9. Substrate oxidation was
determined in perfused hearts using
13C NMR and gene
expression probed using real-time PCR. In Group-1,
myocardial expression of PPARα and PPARα-regulated
genes was significantly down-regulated in AC vs. Control
(Con), consistent with a marked reduction in palmitate
oxidation. In Group-2, expression of PPARα, mCPT1 and
MCAD was markedly upregulated in AC with normal-
isation of palmitate oxidation [AC 37±3% vs. Con 36±4%]
whilst UCP3 expression remained low. Function declined
markedly[Rate pressureproduct ×10
3 (mmHg/min) AC 19±
1† vs. Con 18±1 #, †p<0.05 vs. AC in Group-1, #p<0.05
vs. Con in Group-1].
ModelPPARα
(Peroxisome
proliferator-
activated
receptor α)
mCPT1
(Carnitine
palmitoyl
transferase)
MCAD
(Medium-
chain
acylCoA
dehydrogenase)
UCP3
(Uncoupling
protein)
Group 1
(n=4)
Con 1.0 1.0 1.0 1.0
AC 0.4±0.1* 0.5±0.1* 0.7±0.0* 0.4±0.1*
Group 2
(n=4)
Con 5.1±0.6* 2.6±0.3* 1.6±0.1* 1.3±0.2
AC 2.7±0.2* 1.5±0.1* 1.4±0.1* 0.5±0.1*
Data normalised to Calsequestrin-2 in each group. *p<0.05 vs.
Con in Group 1
Three weeks of high-fat feeding reversed metabolic and
transcript adaptations in CH but with a marked deteriora-
tion in function. In conclusion, high-fat feeding exacer-
bates contractile dysfunction in CH despite a reversal of
cellular remodelling.
Erythropoietin Treatment Normalises Fatty Acid
Oxidation, but not Function, in the Chronically Infarcted
Rat Heart
Mark Cole
1, Carolyn Carr
1, Lisa Heather
1, Emma Carter
1,
Regien Schoemaker
2, Kieran Clarke
1
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Cardiovasc Drugs Ther (2008) 22:133–158 153 153In the chronically infarcted rat heart, oxidation of fatty
acids is reduced, as are other markers of cardiomyocyte
fatty acid handling (Heather et al, 2006). In vivo function in
the infarcted rat heart has been improved using erythropoi-
etin (EPO) treatment (Van de Meer et al. 2005), suggesting
that oxygen delivery is important after infarction and may
underlie changes in fatty acid metabolism. Here, we
examined the effect of EPO treatment on oxygen consump-
tion and fatty acid oxidation in the chronically infarcted rat
heart. Myocardial infarction was performed in male Wistar
rats (200 g, n=15). A subset of 8 infarcted animals was
subsequently treated with 40 μg/kg EPO i.p. at 3 and
6 weeks post infarction (EPO infarcts). Infarcted hearts at
10 weeks had ejection fractions of 45±4% compared with
74±3% in sham-operated animals (n=8, p<0.01), assessed
using in vivo cine MRI. EPO treatment did not improve the
ejection fraction. The heart/body weight ratios of all infarcted
rats were the same with or without EPO treatment, and were
significantly greater than sham-operated rats. At 15 weeks
post infarct, hearts were excised and perfused in Langendorff
mode with Krebs–Henseleit buffer containing 11 mM
glucose plus 0.4 mM palmitate, containing 0.2 μCi ml
−1
[9,10−
3H] palmitate. Rate pressure products for all infarcted
rat hearts were significantly lower than shams, and corre-
lated positively (p<0.001) with the in vivo ejection fractions
(see below). Oxygen consumption, measured using chemi-
luminescence, was reduced to the same extent in all in-
farcted rat hearts compared with shams (p<0.05). However,
fatty acid oxidation was significantly reduced in infarcted rat
hearts compared to shams, but not in EPO-treated infarcted
hearts. EPO treatment therefore prevented the decrease in
fatty acid oxidation associated with chronic myocardial
infarction. Functional improvement may result from more
prolonged EPO treatment.
References
Heather et al. Cardiovasc Res. 72: 430–7, 2006.
Van de Meer et al. J Am Coll Cardiol. 46: 1 25–33, 2005.
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Opposite Correlations of Cardiac Palmitate Oxidation
Rates and Plasma Free Fatty Acids with Ejection
Fractions in the Infarcted Rat Heart
Anthony F Catchpole, Carolyn A Carr, Lisa C Heather,
Kieran Clarke
Department of Physiology, Anatomy and Genetics, University
of Oxford, Oxford, UK
Background: Under normal physiological conditions the
heart derives most of its energy from fatty acid oxidation.
Infarcted, failing rat hearts six months after surgery have
decreased palmitate oxidation rates.
Objectives: To determine the degree of cardiac impairment
in rat hearts ten weeks after infarction, whether cardiac
palmitate oxidation rates are increased or decreased, and
whether the two are related.
Methods: Male Wistar rats were subjected to left coronary
artery ligation (n=5) or sham operation (n=6). Cardiac
function and morphology were evaluated using cine MRI at
one and ten weeks. At 10 weeks,
3H-palmitate oxidation
was determined in isolated, Langendorff-perfused hearts.
Medium chain acyl-CoA dehydrogenase (MCAD) activity
and fasting plasma free fatty acid (FFA) concentration were
determined using enzyme assays.
Results: At one week, infarcted heart end diastolic volumes
were increased by 29% (p<0.05). At ten weeks end diastolic
volumes were increased by 55% (p<0.001) and left
ventricular mass increased by 11% (p<0.01),comparedwith
shams. At ten weeks, cardiac palmitate oxidation correlated
positively, and plasma FFA concentration correlated nega-
tively, with ejection fractions (see figure). Left and right
ventricular MCAD activity and lung wet weight/dry weight
ratio were the same for both groups.
Conclusions: Rat hearts were hypertrophied and dilated at
ten weeks after infarction, but pulmonary congestion and
reduced MCAD levels, suggesting heart failure, were not
observed. Despite the elevated plasma FFA levels in
infarcted animals, rates of cardiac palmitate oxidation were
decreased, potentially caused by reduced cardiomyocyte
FFA uptake.
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Background: Skeletal muscle fatigue and dysfunction has
been reported in rats using a myocardial infarction model of
heart failure, however there is very little evidence regarding
skeletal muscle dysfunction in the aortic banding model of
cardiac hypertrophy.
Objectives: This project aimed to determine whether
skeletal muscle dysfunction is present in rats with aortic
banding-induced pressure overload.
Methods: Male Sprague–Dawley rats (9–10w) underwent
abdominal aortic banding or sham surgery. Muscle
function tests were performed 15w following surgery
using the auto-perfused hind limb. Contractile properties
of the gastrocnemius-soleus-plantaris (GSP) muscle bundle
were determined using two protocols: repetitive single
twitch contractions (1 Hz, 5min) with 50 Hz, 1sec tetanus
before and after and; repeated bouts of low-frequency
stimulation (5 Hz for 5 s of every 10s, for 5min).
Results: Aortic banding resulted in a 22% increase in heart
weight to tibia length ratio after 15w (mean±SEM sham vs
banded, 2.85±0.06 vs 3.47±0.26, p<0.01). Lung weight to
tibia length ratio was not different in banded rats (2.76±
0.09 vs 2.77±0.13, p=0.93) nor was muscle size (GSP to
tibia length ratio, 6.77±0.21 vs 6.65±0.32, p=0.75). There
was no effect of banding on any parameter of muscle
contractile function analysed (absolute forces and contrac-
tion and relaxation rates, rates of fatigue; all p>0.05) in
either stimulation protocol.
Conclusions: Although there was significant cardiac hyper-
trophy observed with banding there were no symptoms of
heart failure, indicating that after 15weeks the heart was in a
state of compensated hypertrophy. In this compensated state,
there was no early indication of skeletal muscle dysfunction.
Regulation of Myocardial Metabolic Gene Expression
in Pressure-Overload and Exercise-induced Hypertrophy
Michael Schwarzer, Christian Riehle, Gracjan Pytel,
Heiko Bugger, Daniel Blum, Torsten Doenst
University of Leipzig and Heart Center Leipzig, Leipzig,
Germany
Background: Hypertrophy can be induced by pressure-
overload or treadmill running. Pressure-overload hypertro-
phy has been associated with distinct changes in gene
expression. The regulatory mechanisms in exercise-induced
hypertrophy are largely unknown.
Objective: To compare the expression of metabolic genes
and their regulators in exercise-induced and pressure-
overload hypertrophy.
Methods: Exercise-induced hypertrophy was induced by
treadmill running of male Sprague Dawley rats for 10 weeks.
Pressure-overload hypertrophy was induced by aortic band-
ing for 14 days. Contractile function was assessed by echo-
cardiography. Expression of glucose (GO) and fatty acid
oxidation (FAO) genes, as well as regulators of metabolic
gene expression, were assessed by RT-PCR.
Results: Both interventions caused significant hypertrophy
(heart-to-body-weight ratio +17.0% Banding, +14.3% Exer-
cise, p<0.05) without affecting left ventricular function
(normal EF). Contrary to expectations, exercise-induced hy-
pertrophy was not associated with any changes in the ex-
pression of FAO genes or the PPARg-coactivators (PGC)-1a
a n d- 1 b .I nc o n t r a s t ,p r e s s u r e - o v e r l o a ds h o w e dac l e a rt r e n d
towards reduced expression of FAO-genes (MCAD −43%
p<0.05, LCAD −20%, p<0.05, FABP −26%, p<0.01, CPT1
−20%, FATP −19%), accompanied by reduced expression of
PGC-1a and -1b (−40% and −35%, respectively, p<0.01).
Expression of putative suppressors of PGC-1a was either
unchanged or even reduced both in exercise-induced and
pressure-overload hypertrophy (Akt, H11K, Cdk9, HIF1a).
Conclusions: Pressure-overload and exercise-induced hy-
pertrophy appear to have different regulatory mechanisms
governing substrate selection and oxidation. The lack of
major differences in expression patterns after treadmill
running may be a reflection of a new steady state of gene
expression as part of a physiological hypertrophic response.
Development of Hypertrophy and Heart Failure
by Minimally Invasive Aortic Constriction in C57/Bl6 Mice
Gloria Färber, H. Frederico Barreto-Pereira, Ralf Gilsbach,
Michael Schwarzer, Lutz Hein, Torsten Doenst
University of Leipzig and Heart Center Leipzig, Germany
Objective: To assess the ability of minimally invasive
transverse aortic constriction to induce heart failure in
wildtype mice and assess the role of PGC-1α and β and
their regulatory targets.
Cardiovasc Drugs Ther (2008) 22:133–158 155 155Methods: Transverse aortic constriction (TAC) was per-
formed through a mini-sternotomy without intubation. The
aortic arch was constricted to 27G (n=40, sham n=12).
Hypertrophy was assessed by the heart/body–weight ratio
and histological analyses. Contractile function was assessed
by intracardiac pressure measurements using a Millar
catheter. Selected metabolic genes were assessed with
quantitative RT-PCR.
Results: Perioperativesurvivalaveragedat70%.Twomonths
after the operation, TAC induced significant hypertrophy
(ventricle–body weight ratio: TAC 7.3±0.5mg/g vs. sham
4.5±0.1mg/g, p<0.05). 25% of the TAC mice displayed signs
of heart failure (pleural effusions, dyspnea, weight loss). All
of them had ventricle-to-body-weight ratios above 10. TAC
mice with ventricle-to-body-weight ratios between 6 and 10
demonstratedcompensated hypertrophy withnormaldp/dtmax
(6621±774mmHg/sec vs. sham 6606±569mmHg/sec) and
no clinical heart failure signs. Rate-pressure products
(min
−1x mmHg/mgBW) were 508±38 in sham, 446±30 in
hypertrophied (n.s.), and 157±64 in failing hearts (p<0.01).
Both hypertrophied and failing hearts showed increased
amounts of fibrosis. There was no change in PGC-1a and -b
expression in hypertrophied heart. In heart-failure, PGC-1b
was near normal but PGC-1α was down-regulated to 32±
7.6% of control (p<0.01, consistent with decreased PPARg
and fatty acid oxidation gene expression.
Conclusions: Minimally invasive transverse aortic con-
striction causes heart failure in a significant fraction of
wildtype mice. This pressure-induced heart failure is indeed
associated with a down-regulation of PGC-1α and β-
oxidation genes.
Autophagy Regulates Remodeling in Unloaded Heart
Mitra Rajabi, Rebecca L Salazar, Peter Razeghi, Stanislaw
Stepkowski, Heinrich Taegtmeyer,
University of Texas-Houston, Houston, TX, USA
Background-Clinical reports have shown that left ventric-
ular assist device implantation may improve cardiac
function in patients with end-stage heart failure. This has
been associated with a decrease in cardiomyocyte size. The
mechanisms for unloading-induced cardiomyocyte atrophy
(reverse remodeling) are not fully understood. In failing
heart apoptotic and autophagic cell death are increased.
Whether autophagy changes with mechanical unloading is
unknown.
Hypothesis—Autophagy is activated in mechanical
unloading of the failing heart.
Methods—Male rats underwent heterotopic heart trans-
plantation (transplantation of a rat heart into a heterotopic
position). Animals were sacrificed at different time points
after the surgery, then the native and the transplanted hearts
were removed, freeze clamped, weighed, and processed for
protein extraction and histology. The heart to body weight
ratio was calculated and compared between groups as an
indicator of atrophy. To determine autophagic activity we
measured expression of microtubule-associated protein
light chain 3 (LC3), which is a specific marker to monitor
autophagy.
Results—As expected, the heart weight to body weight
ratio of the unloaded hearts decreased by 24% and 56%,
one week and one month after transplant, respectively. The
histology revealed a significant decrease in ventricular
cardiomyocytes size in unloaded hearts. Protein analysis
using anti LC3 antibody showed increased expression of
LC3 II in unloaded hearts demonstrating ongoing autopha-
gic activity in those samples.
Conclusion—Mechanical unloading of the heterotopic trans-
planted rat heart shows activation of autophagy which may
play a role in atrophic remodeling of heart through degrada-
tion of proteins and unused organelles after unloading.
Calpain 1 Gene Expression and Calpain-Like Protease
Activity Increase with Atrophic Remodeling of the Heart
Peter Razeghi, Kedryn Baskin, Kaelin Volpini, Heinrich
Taegtmeyer
Department of Internal Medicine, Division of Cardiology,
University of Texas Health Science Center at Houston TX,
USA
Background: Cardiac hypertrophy is an independent risk
factor for the development of heart failure. Regulators of
cardiomyocyte atrophy are potential targets for reversing
cardiac hypertrophy. Calpain 1 and calpain 2 are essential
regulators of skeletal muscle atrophy. Their role in heart
muscle is undefined.
Hypothesis: Calpain 1 and 2 regulate cardiomyocyte
atrophy.
Methods: We used two models of unloading-induced
cardiac atrophy and one model of starvation-induced
cardiomyocyte atrophy. Failing human hearts of 10 patients
(8 men, age: 40.4±5.7) were unloaded with a left
ventricular assist device (mean duration was 200±38 days,
range: 64–437 days). Myocardial samples were obtained
from failing human hearts before and after mechanical
unloading. Normal rat hearts were unloaded for 7 days by
heterotopic transplantation into the abdomen of a recipient
rat. Neonatal rat ventricular cardiomyocytes (NRVM) were
starved of amino acids for 18 hours. Using quantitative RT-
PCR we measured transcript levels of calpain 1 and calpain
156 Cardiovasc Drugs Ther (2008) 22:133–1582 at baseline and after treatment. In the unloaded rat hearts
we also measured calpain-like protease activity.
Results: In patients with left ventricular systolic dysfunc-
tion, mechanical unloading increased cardiac transcript
levels of calpain 1 but unloading did not significantly
change calpain 2 gene expression. The change in calpain 1
transcript levels correlated negatively with the duration of
unloading (r
2=−0.73, p<0.01). Unloading of the hetero-
topically transplanted rat heart significantly increased
calpain 1 transcript levels and calpain-like protease activity.
In nutrient deprived NRVM (no amino acids) calpain 1
transcript levels increased.
Conclusions: Calpain 1 gene expression and activity
increases during cardiomyocyte atrophy suggesting that
calpain 1 may regulate reversal of hypertrophy. Future
studies will examine the trophic effect of calpain 1
inhibitors in models of atrophy and calpain 1 activators in
models of hypertrophy.
Excess Endothelin-1 and Reperfusion Injury in Rabbit
Myocardial Infarction and Isolated Rabbit Cardiomyocytes
Sophie Tamareille*, James Amirian*, Patricia Felli*, Yong
J. Geng*, Fenghua Li
†, William H. Barry
†, Richard W.
Smalling*
Division of Cardiovascular Medicine, University of Texas
at Houston Medical School* and University of Utah Health
Science Center, Salt Lake City
†
Background—The mechanisms by which left ventricular
(LV) unloading limits infarct size in acute myocardial
infarction are unknown.
Hypothesis—We tested the hypothesis that endothelin-1
(ET-1) causes myocyte calcium (Ca
2+) overload which
results in myocardial reperfusion injury and can be
inhibited by LV unloading immediately prior to reperfusion.
Methods—12 anesthetized rabbits were subjected to 1 hour
of left circumflex coronary artery occlusion followed by
3 hours of reperfusion. Unloading was initiated 15 min prior
to reperfusion and maintained during the entire period of
reperfusion (unloaded group, n=6). A control group (n=6)
was subjected to reperfusion alone. In parallel, isolated
rabbit myocytes were subjected to simulated ischemia/
reperfusion with and without ET-1 and intracellular Ca
2+
was assessed with flow cytometry.
Results—Just prior to reperfusion, LV unloading signifi-
cantly decreased the LV end-diastolic pressure. Infarct size,
expressed as a percentage of zone at risk, was also
significantly reduced in the unloaded group compared to
controls (3.39±1.35% vs 17.50±4.52%, P=0.013). Unload-
ing support significantly reduced ET-1 release from the
heart at2 hours of reperfusion (21.37±2.83pg/mL vs54.34±
11.34 pg/mL, P=0.03). LV unloading caused a significant
reduction in the % of apoptotic cells (2.75±0.38% vs 5.84±
1.97%, P=0.003) in the ischemic region. In isolated
ventricular myocytes subjected to simulated ischemia/
reperfusion, ET-1 at physiologic levels increased Ca
2+
uptake and decreased myocyte viability.
Conclusions—Our results suggests that ET-1 release by
ischemic myocardium at the time of reperfusion results in
fatal myocardial Ca
2+ overload and is likely an important
mediator of reperfusion injury.
Malonyl CoA Decarboxylase Deficient Mice Display
Minimal Infarct During In Vivo Ischemia/Reperfusion
Wei Wang, John Edward R. Ussher, Shaohua Wang, Jason
R.B. Dyck, Gary D. Lopaschuk
Cardiovascular Research Group. Departments of Pediat-
rics, Pharmacology, and Surgery, University of Alberta,
Canada
During reperfusion of the ischemic myocardium, fatty acid
oxidation (FAO) rates quickly recover, while glucose
oxidation (GOX) rates remain low. This results in an
uncoupling between glycolysis and glucose oxidation,
leading to an increased proton production, which decreases
cardiac efficiency during the critical stages of reperfusion.
Malonyl CoA decarboxylase (MCD), an enzyme responsi-
ble for degrading malonyl CoA, relieves malonyl CoA-
dependent inhibition of carnitine palmitoyl transferase-1,
resulting in an increased rate of FAO. Studies have shown
that inhibition of MCD improves the reperfusion recovery
of ischemic hearts by reducing rates of FAO and increasing
rates of GOX. The objective of this study was to determine
whether inhibition of MCD results in decreased infarct size.
WT or MCD knockout (MCD
−/−) mice were anaesthetized
and subjected to temporary left anterior descending coro-
nary artery ligation for 30 min followed by 24 hrs of
reperfusion. At the end of reperfusion, hearts were removed
and perfused with Evans blue to delineate the area at risk,
and then stained in 1% triphenyltetrazolium chloride at
37
oC for 10 min to determine infarct size. MCD
−/− mice
demonstrated a dramatic reduction in overall infarct size
compared to WT mice (10.80+4.04% vs. 39.50+4.01% of
area at risk) with similar areas at risk (53.00+8.99% vs.
51.90+5.93% of left ventricle).
This study demonstrates that inhibition of MCD may be
beneficial for the treatment of ischemia/reperfusion injury,
further validating the optimization of cardiac energy
metabolism as a novel therapy for ischemic heart disease.
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Expression to Reduce Glucose Oxidation
Malika Chegary, Heleen te Brinke, Frits Wijburg, Ronald
Wanders, Sander Houten
Laboratory Genetic Metabolic Diseases, Departments of
Clinical Chemistry and Pediatrics, Academic Medical
Center, Amsterdam, the Netherlands.
Background: Heart disease is a common symptom in
children with inherited mitochondrial long-chain fatty acid
b-oxidation (FAO) defects. It is unknown whether this is
caused by an energy shortage due to the FAO defect and/or
an accumulation of toxic FAO intermediates. In theory
glucose oxidation can compensate for a defect in FAO.
Glucose oxidation, however, is decreased by fatty acids, a
process in which pyruvate dehydrogenase kinase 4 (PDK4)
plays an important role. Elevated PDK4 levels have been
reported in a FAO-deficient mouse model.
Hypothesis/objectives: To determine the effect of a FAO
defect on PDK4 expression levels and glucose metabolism.
Methods: We studied the transcriptional regulation of PDK4
in so-called “Fao” cells. “Fao” cells are characterized by
substantial PDK4expression levelsand no lactate production.
FAO was inhibited using L-aminocarnitine. Glucose oxida-
tion and FAO were assessed using radiolabeled substrates.
Results: We confirm that PDK4 expression is induced by
fatty acids. Inhibition of FAO by L-aminocarnitine did not
have any effect on PDK4 expression. In contrast, fatty acids
and AMP-activated protein kinase (AMPK) activation by
AICAR synergistically induced PDK4 expression. During
hypoxia, which also activates AMPK, fatty acids induced
PDK4 expression more effectively than during normoxia.
AMPK activation decreased glucose oxidation and as a
consequence increased lactate formation, producing a
decreased nucleotide triphosphate pool.
Conclusions: AMPK and fatty acids synergistically in-
crease PDK4 expression and decrease glucose oxidation.
This cooperation makes cells more dependent on FAO. In
the case of an inherited FAO defect this is a maladaptation.
Impact of Hormone Replacement Therapy on Myocardial
Fatty Acid Metabolism
Pablo F. Soto, Pilar Herrero, Tingting Turski, Ken Schechtman,
Valerie Ratts and Robert J. Gropler.
Washington University School of Medicine, St. Louis, MO.
Background: Studies in experimental animals demonstrate
that estrogen (E) increases myocardial fatty acid oxidation
(MFAO). Recently, we reported that myocardial oxygen
consumption (MVO2) as well as MFAO were increased in
post-menopausal women receiving E, and that progesterone
appeared to attenuate this effect. However, the study was
retrospective.
Hypothesis/ Objectives. To determine, prospectively, if
short-term administration of E, alone or in combination
with progesterone (EP), will alter MVO2 or MFAO in post-
menopausal women.
Methods. Fifteen post-menopausal women (age 63±7 yrs)
not previously on hormone replacement therapy (HRT)
underwent quantitative assessment of myocardial blood
flow (MBF), MVO2, and fractional fatty acid uptake
(MFAuptake) as well as overall fatty acid utilization
(MFAU) and MFAO using positron emission tomography
with
15O-water,
11C-acetate and
11C-palmitate, respectively.
Rate pressure product (RPP) was used to estimate cardiac
work. Measurements were performed at baseline and after
3-days of estradiol (0.3 mg/day via transdermal patch) and
either progesterone (200 mg/day orally) or placebo.
Results: After E or EP, both MBF and MVO2 were
unchanged from baseline. Additional findings:
Means±SD E (n=7) EP (n=8)
Baseline (+) E p Baseline (+) E+P P
Free Fatty Acid
(nmol/mL)
655±
332
502±
188
.03 686±
207
851±
313
.11
RPP
(mm Hg min
−1)
7751±
1503
7224±
1782
.01 7338±
2852
7044±
1929
NS
MFA uptake
(mL g
−1 min
−1)
.34±.08 .36±.05 NS .32±.06 .34±.03 NS
MFAU
(nmol g
−1 min
−1)
143±93 105±36 .17 121±44 167±75 .07
MFAO (nmol g
−1
min
−1)
133±89 95±35 .18 106±47 143±63 .02
MFAU/RPP × 10
4 19±13 15±6 NS 18±8 24±12 .07
MFAO/RPP × 10
4 18±13 14±6 NS 13±5 20±9 .01
Conclusions: Short-term E therapy lowers plasma FFA and
tends to lower overall MFAU or MFAO independent of
cardiac work. Combined EP administration increases
MFAU and MFAO relative to the amount of cardiac work
performed. These changes appear to be mediated by
peripheral changes in plasma FFA. The long-term effects
of HRT on cardiac metabolism and its impact on cardiac
risk profile and function remains to be determined.
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